好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2011 Annual Meeting | Poster Session 05

Wednesday 04/13/11
02:00 PM - 06:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Sleep, Aging and Dementia, Anterior Horn, Child Neurology/Developmental Neurobiology, Clinical Neurophysiology, Epilepsy, Headache, Infections/AIDS/Prion Disease, Interventional Neurology, MS and Related Diseases, Neurogenetics and Gene Therapy, Neurologic 好色先生, Neurotoxicology
No CME available
Event Timeline
02:00 PM - 06:30 PM Abstract 001 - Effectiveness of Podcasting in a Neurology Residency Training Program
02:00 PM - 06:30 PM Abstract 002 - Acquiring Medical Knowledge through Podcasting in a Neurology Training Program
02:00 PM - 06:30 PM Abstract 003 - Individual Learning Style Preference and It's Impact on 好色先生 in a Neurology Residency Training Program
02:00 PM - 06:30 PM Abstract 004 - Doing Away with the "Halo" and/or "Horns" Effect Bias: Competency-Based Resident Assessment Matrix Linked to the Six ACGME Competency Domains
02:00 PM - 06:30 PM Abstract 005 - Evaluating Incoming Neurology Residents on Day Two of the Residency: A Neurology Residency's Approach To Establishing a Baseline
02:00 PM - 06:30 PM Abstract 006 - The European Board of Neurology Examination: Junior Neurologists Hold Interest in Quality Assurance and Acquisition of European Standards
02:00 PM - 06:30 PM Abstract 007 - Is a Neurophysiology OSCE a Good Predictor for the RITE?
02:00 PM - 06:30 PM Abstract 008 - Telemedicine: An Important Tool of Resident Learning
02:00 PM - 06:30 PM Abstract 009 - Neurology Residents Believe That More Interventional Neurology Exposure Will Translate into Better Patient Care: A Nationwide Survey
02:00 PM - 06:30 PM Abstract 010 - A System for Rapid Peer Review of Online Materials for Neurology 好色先生
02:00 PM - 06:30 PM Abstract 011 - Testing or Elaboration: Which One Promotes Better Retention in Neurological 好色先生?
02:00 PM - 06:30 PM Abstract 012 - The Effects of Electronic Health Record Implementation on Medical Student Educators: A Survey of Clinical Faculty
02:00 PM - 06:30 PM Abstract 013 - Effectiveness of Simulating a Cranial Nerve Examination Using a Virtual Patient and the Nintendo Wiimote[reg]
02:00 PM - 06:30 PM Abstract 014 - Assessing Medical Students' Performance of Focused Neurologic Evaluations: Does Ability Correlate with Interest in and Perception of Neurology?
02:00 PM - 06:30 PM Abstract 015 - Teaching Neuroscience in Context Using a Clinical Presentation-Based Curriculum and Introductory Diagnostic Schemes
02:00 PM - 06:30 PM Abstract 016 - Why Do US Medical Students Choose Neurology as a Career? Results of a Multicenter Cross-Sectional Survey of US Medical School Seniors
02:00 PM - 06:30 PM Abstract 017 - Does Medical Student Neurology Knowledge Correlate with Performance on the Neurological Examination?
02:00 PM - 06:30 PM Abstract 018 - Neurology Clerkship: A Survey To Assess 好色先生al Experience and Potential Areas of Improvement
02:00 PM - 06:30 PM Abstract 019 - Evaluator Unfamiliarity Is Common and Can Affect Medical Student Assessment
02:00 PM - 06:30 PM Abstract 020 - Evaluation of Medical Student Written Case Reports in the Neurology Clerkship
02:00 PM - 06:30 PM Abstract 021 - A Multimedia Tutorial on Primitive Reflexes
02:00 PM - 06:30 PM Abstract 022 - A Pr[eacute]cis to Demystify Neuroanatomical Localization
02:00 PM - 06:30 PM Abstract 023 - The Combined Treatment of Glatiramer Acetate (GA) and Salirasib Attenuates Experimental Autoimmune Encephalomyelitis (EAE)
02:00 PM - 06:30 PM Abstract 024 - Remyelination and Preservation of Motor Neurons by Glatiramer Acetate Treatment in Mice with Experimental Autoimmune Encephalomyelitis
02:00 PM - 06:30 PM Abstract 025 - Isotonic Saline Subjected to Taylor-Couette-Poiseuille Flow Demonstrates Anti-Inflammatory Activity in Rodent Models of Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 026 - Anti-Inflammatory Effects of Copaxone on the Level of Adhesion Molecule Expression Patterns during Short- and Long-Term Treatment
02:00 PM - 06:30 PM Abstract 027 - Estrogen-Induced Protection Against Experimental Encephalomyelitis Is Abrogated in the Absence of B-Cells
02:00 PM - 06:30 PM Abstract 028 - Vascular Adhesion Protein-1 (VAP-1) Expression in Multiple Sclerosis Brain and Its Involvement in Disease Pathogenesis in EAE
02:00 PM - 06:30 PM Abstract 030 - Effect of Laquinimod on Cuprizone-Induced Demyelination in Mice
02:00 PM - 06:30 PM Abstract 031 - ACTH Induces Proliferation of Astrocytes In Vitro
02:00 PM - 06:30 PM Abstract 032 - Neuroprotective Potential of Fumaric Acid Esters in a Model of Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 033 - Eletroacupuncture Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Modulating Immune Response
02:00 PM - 06:30 PM Abstract 034 - The Active Metabolite of BG-12, Monomethyl Fumarate Is Transported across the Blood-Brain Barrier: Single- and Multiple-Dose Studies in Mice
02:00 PM - 06:30 PM Abstract 035 - Glatiramer Acetate Treatment Protects Synaptic Transmission in Experimental Autoimmune Encephalomyelitis
02:00 PM - 06:30 PM Abstract 036 - Cigarette Smoke Induction of Inflammation in Brains of Lewis Rats
02:00 PM - 06:30 PM Abstract 037 - Neuroprotective Effects of BG-12 and Other Fumarates on Primary Cultures of Neurons and Astrocytes after Oxidative Challenge
02:00 PM - 06:30 PM Abstract 038 - Reduction of Disease Severity in EAE and Protection of Cultured Oligodendrocytes by a Nicotinic Receptor Agonist
02:00 PM - 06:30 PM Abstract 039 - Dietary Vitamin D3 Supplement Reduces Demyelination in the Cuprizone Model
02:00 PM - 06:30 PM Abstract 040 - Comparison of the Efficacy and Tolerability of a Novel Methyl Hydrogenfumarate Prodrug with Dimethyl Fumarate in Rodent EAE and GI Irritation Models
02:00 PM - 06:30 PM Abstract 041 - Predictive Value of Cervical Lesions for Conversion to Multiple Sclerosis in Patients with Clinically Isolated Syndromes
02:00 PM - 06:30 PM Abstract 042 - Effect of Alemtuzumab vs. Interferon beta-1a on Brain Atrophy in Patients with Early, Active Relapsing-Remitting Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 043 - DTI Tractography Correlates with OCT and Confirms Hemi-Field Defect: A Unique Presentation of Post-Chiasmatic Neuromyelitis Optica
02:00 PM - 06:30 PM Abstract 044 - Corpus Callosum Cross-Sectional Area Is Associated with Inductive Reasoning and Visuo-Spatial Skills in Relapsing-Remitting Multiple Sclerosis Patients
02:00 PM - 06:30 PM Abstract 045 - Clinical and Magnetic Resonance Imaging Predictors of Long-Term Outcomes in Patients with Relapsing-Remitting Multiple Sclerosis: Additional Analyses
02:00 PM - 06:30 PM Abstract 046 - Cortical Thickness in Multiple Sclerosis: Correlation to Disease Duration and Disability
02:00 PM - 06:30 PM Abstract 047 - Cerebrovascular Autoregulation and Vasoreactivity in Multiple Sclerosis Patients
02:00 PM - 06:30 PM Abstract 048 - Cortical Atrophy in Males in Multiple Sclerosis: Gender Differences in Patients with Early Relapsing Remitting Multiple Sclerosis (RRMS) - Magnetic Resonance Imaging (MRI) Longitudinal 5 Year Follow up Study
02:00 PM - 06:30 PM Abstract 049 - Tumefactive Demyelinating Lesion in a Patient with Advanced Human Immunodeficiency Virus Infection
02:00 PM - 06:30 PM Abstract 050 - Optical Coherence Tomography in Clinically Isolated Syndrome and Multiple Sclerosis as a Measure of Brain Atrophy
02:00 PM - 06:30 PM Abstract 051 - Measurements of Brain Iron in Patients with Multiple Sclerosis Using Quantitative T2* Mapping at 7 Tesla
02:00 PM - 06:30 PM Abstract 052 - Posterior Fossa and Cervical Lesion Distribution in Progressive Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 053 - Addition of Azathioprine and Corticosteroids to the Interferon Therapy Reduces Long-Term Clinical Progression in Multiple Sclerosis Patients with High T2-Lesion Volume
02:00 PM - 06:30 PM Abstract 054 - Global and Regional Cortical Thickness Correlates of Cognitive Function in Cognitively Impaired Patients with Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 055 - Characterization of Deep Gray Matter T2 Hypointensity in a Murine Model of Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 056 - Brain Atrophy over 1 Year of Disease Onset Predicts Long Term Clinical Status in Relapsing Remiting Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 057 - Acute Demyelinating Lesions with Restricted Diffusion (ADLRD) in Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 058 - Association between Changes in Gray Matter MRI Measures and Disability Progression over 5 Years in Patients Treated with IM IFN[beta]-1a
02:00 PM - 06:30 PM Abstract 059 - Relapse Score and Brain Atrophy Predict the Response to Therapy in Individuals with Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 060 - Cerebral and Spinal 3.0 Tesla MRI Compared to 1.5 Tesla MRI in MS: Impact in Clinical Routine
02:00 PM - 06:30 PM Abstract 061 - Perivascular Distribution of White Matter Pathology in Different MS Phenotypes Using 7T MRI
02:00 PM - 06:30 PM Abstract 062 - Susceptibility-Weighted Imaging Iron Quantification Does Not Correlate with Deep Gray Matter Injury in MS: Results of a Pilot Longitudinal Study in RRMS
02:00 PM - 06:30 PM Abstract 063 - MRI Texture Analysis Appears To Differentiate Astrocytoma from Tumefactive MS Lesions
02:00 PM - 06:30 PM Abstract 064 - Fingolimod Reduces Brain Volume Loss in Relapsing-Remitting Multiple Sclerosis (RRMS) beyond Its Anti-Inflammatory Activity: Results from FREEDOMS
02:00 PM - 06:30 PM Abstract 065 - Remote EBV Seropositivity at First Attack in Children Increases MS Risk Independent of Other Common Childhood Viruses
02:00 PM - 06:30 PM Abstract 066 - Differences in Genetic Architecture between Subjects with Pediatric- and Adult-Onset Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 067 - Recurrent Demyelinating Events Following Pediatric Optic Neuritis (pON)
02:00 PM - 06:30 PM Abstract 068 - Treatment Decisions in Pediatric Multiple Sclerosis
02:00 PM - 06:30 PM Abstract 069 - Increased Familial Maternal Autoimmune Prevalence in Pediatric Multiple Sclerosis and Monophasic Demyelinating Disorders
02:00 PM - 06:30 PM Abstract 070 - Multiple Sclerosis in Israeli Children: Incidence, Clinical, CSF and MRI Findings
02:00 PM - 06:30 PM Abstract 071 - Comparative Study of MR Venography and Doppler Sonography in Depicting Extra-Cranial Venous Abnormalities in Multiple Sclerosis Patients and Healthy Subjects
02:00 PM - 06:30 PM Abstract 072 - NMO Spectrum Disorder in Children and Adolescents
02:00 PM - 06:30 PM Abstract 073 - The Influence of Home Environment on Cognitive Function in Children with Prenatal Methamphetamine Exposure
02:00 PM - 06:30 PM Abstract 074 - Infections with CMV and, in Those HLA-DRB1*15 Positive, HSV-1, Are Associated with a Lower Risk of Pediatric-Onset MS
02:00 PM - 06:30 PM Abstract 075 - Antibodies to Epstein-Barr Virions Are Increased in Multiple Sclerosis Cerebrospinal Fluid
02:00 PM - 06:30 PM Abstract 076 - Deep Brain Stimulation of the Globus Pallidus Interna in Lesch-Nyhan Syndrome
02:00 PM - 06:30 PM Abstract 077 - Glaidin-Immunized HLA DQ2 Transgenic Mice Do Not Develop Ataxia or Cerebellar Damage
02:00 PM - 06:30 PM Abstract 078 - Childhood-Onset Neurodegeneration Associated with PLA2G6 Gene Mutations: An Evolving Entity of Recessive Ataxia Syndrome
02:00 PM - 06:30 PM Abstract 079 - Adult-Onset Niemann-Pick Type C (NPC): Two New Contrasting Cases
02:00 PM - 06:30 PM Abstract 080 - Digital Spiral Analysis for Objective Quantification of Limb Dysmetria - A Validation Study
02:00 PM - 06:30 PM Abstract 081 - Purkinje Cell Degeneration in a Mouse Model of Marinesco-Sjogren Syndrome
02:00 PM - 06:30 PM Abstract 082 - Effects of Angiotensin II Treatment and Acid-Sensing Ion Channel 1a Knockdown on SCA1 Purkinje Cells
02:00 PM - 06:30 PM Abstract 083 - The Genetic Basis of SPG36 - A Novel Disease Mechanism
02:00 PM - 06:30 PM Abstract 084 - Does Hashimoto's Thyroiditis Predispose to Cerebellar Ataxia in Essential Tremor Patients Undergoing Thalamic Stimulation?
02:00 PM - 06:30 PM Abstract 085 - AMPA Receptor Antibodies Associated with Cerebellar Ataxia: A Case Report Extending the Neurological Spectrum of Paraneoplastic Antibodies
02:00 PM - 06:30 PM Abstract 086 - FXTAS in Patients with Fragile X Gray Zone Alleles
02:00 PM - 06:30 PM Abstract 087 - Case Report: Deep Brain Stimulation of Vim Improves FXTAS Tremor and Ataxia
02:00 PM - 06:30 PM Abstract 088 - Clinical Correlates of Olfactory Dysfunction in Spinocerebellar Ataxia Type 3
02:00 PM - 06:30 PM Abstract 089 - A Combined Nucleic Acid and Protein Analysis in Friedreich's Ataxia: Implications for Diagnosis, Pathogenesis and Clinical Trial Design
02:00 PM - 06:30 PM Abstract 090 - Cathepsin D and Myosin IIB Colocalize with Polyglutamine Aggregates in Spinocerebellar Ataxia Type 6 and Other Polyglutamine Diseases
02:00 PM - 06:30 PM Abstract 091 - Diffusion Tensor Imaging (DTI) and Voxel Based Morphometry (VBM) Analysis Reveal White Matter Abnormalities in Machado-Joseph (MJD) Disease
02:00 PM - 06:30 PM Abstract 092 - Demographics of Friedreich's Ataxia (FRDA) Patients with Idebenone Prescriptions in Canadian FRDA Patient Support Program and Results of a Patient Survey
02:00 PM - 06:30 PM Abstract 093 - Frataxin Measurements in Different Tissues: A Comparison of Two Methods
02:00 PM - 06:30 PM Abstract 094 - Effects of Erythropoietin on Skeletal Muscle Metabolism in Friedreich Ataxia: A Functional MRS Study
02:00 PM - 06:30 PM Abstract 095 - Contributions of SCA2, SCA3 and SCA17 in Korean Patients with Parkinsonism and Ataxia
02:00 PM - 06:30 PM Abstract 096 - A Novel Device for Parkinson's Disease
02:00 PM - 06:30 PM Abstract 097 - Aldehyde Adducts Block DOPAL Toxicity: A New Therapeutic Strategy for Parkinson Disease
02:00 PM - 06:30 PM Abstract 098 - NMDA Antagonists Therapy for Peak-Dose Levodopa-Induced Dyskinesia in Parkinson's Disease: Meta-Analysis of Controlled Clinical Trials
02:00 PM - 06:30 PM Abstract 099 - HDAC6 Increases Chaperone-Mediated Autophagic Clearance of [alpha]-Synuclein in Response to MPP+
02:00 PM - 06:30 PM Abstract 100 - Parkinson's Disease Drug Therapies: Medication Compliance and Persistence Update
02:00 PM - 06:30 PM Abstract 101 - Parkinson's Disease Medication Persistence
02:00 PM - 06:30 PM Abstract 102 - Magnetoencephalography in Non-Lesional Neocortical Partial Epilepsy and Relation to Epilepsy Surgery Outcome
02:00 PM - 06:30 PM Abstract 103 - Ictal Activity, Invisible on Scalp EEG, Seen on Simultaneous MEG
02:00 PM - 06:30 PM Abstract 104 - Vagal Nerve Stimulation and the Immune Modulation in Patients with Refractory Epilepsy
02:00 PM - 06:30 PM Abstract 105 - Indicators of Favorable Outcome with Vagus Nerve Stimulation (VNS) in 50 Patients with Different Kinds of Epilepsy
02:00 PM - 06:30 PM Abstract 106 - Vagus Nerve Stimulation (VNS) in a Pediatric Population - Surgical Technique Considerations in Young Children and Adolescents
02:00 PM - 06:30 PM Abstract 107 - Meta-Analysis of Seizure Freedom with Vagus Nerve Stimulation
02:00 PM - 06:30 PM Abstract 108 - An Audit of EEG Use in a Tertiary Referral Centre
02:00 PM - 06:30 PM Abstract 109 - Interictal Regional Delta Slowing Is an EEG Marker of Epileptic Neural Network in Temporal Lobe Epilepsy
02:00 PM - 06:30 PM Abstract 110 - Source Localization of Oscillatory Components in Bursts of Interictal Rhythmic Epileptic Activity
02:00 PM - 06:30 PM Abstract 111 - Association between Ictal Hypoxemia and Heart Rate Variability in Localization-Related Epilepsy
02:00 PM - 06:30 PM Abstract 112 - Early Involvement of Autonomic Nervous System in Nocturnal Seizures with Right Hemispheric Onset
02:00 PM - 06:30 PM Abstract 113 - Seizure-Related Cardiac Repolarization Abnormalities Associated with Severity of Ictal Hypoxemia
02:00 PM - 06:30 PM Abstract 114 - Connectivity of the Insula: A Cortico-Cortical Evoked Potential Study
02:00 PM - 06:30 PM Abstract 115 - A Multimodal Evaluation of the Basal Temporal Language Area
02:00 PM - 06:30 PM Abstract 116 - The Value of Scalp Spike Frequency as an EEG Marker of Epileptogenesis in Temporal Neocortex in Patients with Mesial Temporal Lobe Epilepsy
02:00 PM - 06:30 PM Abstract 117 - Epilepsies Presenting without Interictal Epileptiform Discharges
02:00 PM - 06:30 PM Abstract 118 - A Novel Means of Clinical Assessment of Laryngeal Nerve Conduction
02:00 PM - 06:30 PM Abstract 119 - Non Invasive High Voltage Electrical Stimulation of Lumbosacral Motor Nerve Roots: A Methodological Study
02:00 PM - 06:30 PM Abstract 120 - Carpal Tunnel Syndrome. Neurophysiological Features in 830 Hands. Normal Routine Studies with Abnormal Median Inching across the Wrist
02:00 PM - 06:30 PM Abstract 121 - Motor Nerve Conduction Study in Cauda Equine with High Voltage Electrical Stimulation in Multifocal Motor Neuropathy and Amyotrophic Lateral Sclerosis
02:00 PM - 06:30 PM Abstract 122 - Sural/Radial SNAP Amplitude Ratio in the Diagnosis of Diabetic Sensorimotor Polyneuropathy
02:00 PM - 06:30 PM Abstract 123 - Significance of Physiological Findings in IVIg/MMN Patients
02:00 PM - 06:30 PM Abstract 124 - Correlation between Electrodiagnostic and Ultrasonographic Evaluation in Diagnosis and Grading of Carpal Tunnel Syndromes
02:00 PM - 06:30 PM Abstract 126 - Clinical, Neurophysiological, and Laboratory Characteristics of Patients with Guillain-Barr[eacute] Syndrome in Mexico
02:00 PM - 06:30 PM Abstract 127 - Single-Fiber Electromyography (SFEMG) Study in Normal Subjects [amp] in Patients with Myasthenia Gravis
02:00 PM - 06:30 PM Abstract 128 - Quantitative Analysis of Lower Motor Neuron Involvement for Spinal and Bulbar Muscular Atrophy
02:00 PM - 06:30 PM Abstract 129 - Electrical Impedance Myography as a Biomarker in Spinal Muscular Atrophy
02:00 PM - 06:30 PM Abstract 130 - Effect of Exercise on Fasciculations in Young Healthy Subjects
02:00 PM - 06:30 PM Abstract 131 - Isolated Bulbar Palsy Phenotype of Amyotrophic Lateral Sclerosis
02:00 PM - 06:30 PM Abstract 132 - The "Split-Hand" Pattern of ALS and Its Occurrence in Ulnar Neuropathy
02:00 PM - 06:30 PM Abstract 133 - Electrophysiologic Correlation of Disease Progression with Spinal Cord Pathology in hSOD1G93A Rats
02:00 PM - 06:30 PM Abstract 134 - Comparison of Motor Units Number Estimation by Bayesian Statistical MUNE with Histological Counting of Motor Unit Numbers: Validation of the Method
02:00 PM - 06:30 PM Abstract 136 - Bayesian Statistical Motor Unit Number Estimation in the Assessment of ALS
02:00 PM - 06:30 PM Abstract 137 - The KEGG ALS Pathway Revisited: A New Model for Microarray Studies
02:00 PM - 06:30 PM Abstract 138 - Genetic Testing in Apparent Sporadic ALS Patients: Surveyed Opinions of the Northeastern ALS Consortium (NEALS) Membership
02:00 PM - 06:30 PM Abstract 139 - An ALS Patient with a Homozygous A382T Missense Mutation of the TARDBP Gene
02:00 PM - 06:30 PM Abstract 140 - Identification of a Novel Locus for Autosomal Recessive Juvenile ALS to Chromosome 9p13
02:00 PM - 06:30 PM Abstract 141 - Familial and Sporadic ALS Associated with a Novel K3E Mutation in the SOD1 Gene
02:00 PM - 06:30 PM Abstract 142 - A Prospective Study of Central Nervous System Abnormalities in Patients with Peripheral Myelin Protein22 (PMP22) Mutations
02:00 PM - 06:30 PM Abstract 143 - Search for Genetic Risk Factors and Phenotypic Modifiers for Sporadic ALS Based on Extensive Resequencing of Causative Genes for Familial ALS
02:00 PM - 06:30 PM Abstract 144 - Preliminary Efficacy Results from a Phase 1 Trial of Vector-Mediated Gene Transfer for Chronic Intractable Pain
02:00 PM - 06:30 PM Abstract 145 - Molecular Epidemiological Study of Familial and Sporadic Amyotrophic Lateral Sclerosis with OPTN Mutations in the Japanese Population
02:00 PM - 06:30 PM Abstract 146 - Parkinsonism, mtDNA Multiple Deletions and Subclinical Optic Neuropathy in a 'OPA1 Plus' Family with a Novel Missense Mutation in the OPA1 Gene
02:00 PM - 06:30 PM Abstract 147 - Distinct Patterns of Spinal Cord Atrophy in Machado-Joseph Disease and Friedreich[acute]s Ataxia
02:00 PM - 06:30 PM Abstract 148 - Diffusion-Tensor Imaging Shows Diffuse White Matter Damage in SPG11
02:00 PM - 06:30 PM Abstract 149 - IGF-1 as a Potential Therapeutic in Patients with Spinal Bulbar Muscular Atrophy
02:00 PM - 06:30 PM Abstract 150 - Histopathologic and Electrophysiologic Characterization of the Rat Model for Hereditary Spastic Paraplegia
02:00 PM - 06:30 PM Abstract 151 - Solving Unsolved Cases of Leukodystrophy in the Pediatric Population
02:00 PM - 06:30 PM Abstract 152 - Global Identification of Genes Required for Neural Differentiation of Human Embryonic Stem Cells by Using RNA Interference Screens Coupled with High-Throughput Sequencing
02:00 PM - 06:30 PM Abstract 153 - Association between COMT Polymorphisms and Apathy in Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 154 - Comparable Rates of Dementia among First Degree Relatives of Patients with Mild Cognitive Impairment and Alzheimer's Disease
02:00 PM - 06:30 PM Abstract 155 - Distinct Default Mode Connectivity in ApoE4-carriers Independent of TOMM40 Poly-T Repeat Length
02:00 PM - 06:30 PM Abstract 156 - Brain Expression Genome-Wide Association Study (eGWAS) in Alzheimer's and Other Neurologic Disease Control Subjects
02:00 PM - 06:30 PM Abstract 157 - Genetic Risk of CR1, CLU, PICALM and TOMM40 in Alzheimer Disease in 2 Canadian Cohorts: CSHA and ACCORD
02:00 PM - 06:30 PM Abstract 158 - Risk Genotypes at TMEM106B Are Associated with Cognitive Impairment in Amyotrophic Lateral Sclerosis
02:00 PM - 06:30 PM Abstract 159 - Exome Sequencing of Extended Late-Onset Alzheimer Families
02:00 PM - 06:30 PM Abstract 160 - Dominantly Inherited Alzheimer Network (DIAN): Registry Characteristics and Biomarker Findings
02:00 PM - 06:30 PM Abstract 161 - Pathway Analysis of Late Onset Alzheimer Disease Implicates the Olfactory Transduction Pathway
02:00 PM - 06:30 PM Abstract 162 - Subjects with MAPT Mutations Perform Poorly in Tests of Naming, but Well on Tests of Executive Function, at Diagnosis Compared to Those with Progranulin Mutations
02:00 PM - 06:30 PM Abstract 163 - Frontal Intermittent Rhythmic Delta Activity (FIRDA) in Children
02:00 PM - 06:30 PM Abstract 164 - Occipital Intermittent Rhythmic Delta Activity (OIRDA) in Children
02:00 PM - 06:30 PM Abstract 165 - A Large Prospective Study of Children with Cyclic Vomiting Syndrome: Single Center Experience
02:00 PM - 06:30 PM Abstract 166 - Filicide-Suicide in Families with Disabled Children
02:00 PM - 06:30 PM Abstract 167 - Self-Directed Online Learning of Child Neurology for Medical Students
02:00 PM - 06:30 PM Abstract 168 - Identification of Prehypsarhythmia in Infants at Risk of Symptomatic West Syndrome
02:00 PM - 06:30 PM Abstract 169 - Clinical Staging and Evolution of Continuous Spikes and Waves during Sleep (CSWS)
02:00 PM - 06:30 PM Abstract 170 - Encephalitis Associated with Human Metapneumovirus: Report of Two Additional Cases and Review of the Literature
02:00 PM - 06:30 PM Abstract 171 - Lambert Eaton Myasthenic Syndrome in a 3-Year-Old Boy
02:00 PM - 06:30 PM Abstract 172 - The Efficacy and Safety of a Combination Product Containing Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents
02:00 PM - 06:30 PM Abstract 173 - Preventative Treatment of Childhood and Adolescent Migraines with Topiramate and Amitriptyline: A Retrospective Analysis Comparing Their Dose Based Effectiveness in Reducing Migraine Frequency and Associated Symptoms
02:00 PM - 06:30 PM Abstract 174 - Intravenous Immunoglobulin Is More Cost Effective Than Plasmapheresis in the Treatment of Pediatric Guillain-Barre Syndrome
02:00 PM - 06:30 PM Abstract 175 - Effectiveness in Treatment of Spastic Cerebral Palsy in Children with Botulinum Toxin Type A in a Medical Center at Mexico City (Centro Medico Nacional 20 De Noviembre)
02:00 PM - 06:30 PM Abstract 176 - Stereotactic Thermoablation of Epileptogenic Foci by Feedback-Controlled Laser in Pediatric Epilepsy
02:00 PM - 06:30 PM Abstract 177 - Lenalidomide in Regressive Autism: Improved Language Testing and Decreased TNF-[alpha], IL-1[alpha], IL-1[beta] Levels with Treatment
02:00 PM - 06:30 PM Abstract 178 - Mechanical Embolectomy in Acute Large Vessel Ischemic Stroke in Children
02:00 PM - 06:30 PM Abstract 179 - Off-Label-Thrombolysis for Acute Ischemic Stroke: Rate, Clinical Outcome and Safety Are Influenced by the Definition of "Minor Stroke"
02:00 PM - 06:30 PM Abstract 180 - Outcomes of Acute Stroke Therapies in the Elderly
02:00 PM - 06:30 PM Abstract 181 - Successful Endovascular Acute Stroke Intervention Prevents Infarct Core Growth
02:00 PM - 06:30 PM Abstract 182 - Neurological Outcomes in Acute Ischemic Stroke Patients Receiving Endovascular Therapy beyond 3 Hours
02:00 PM - 06:30 PM Abstract 183 - Penumbra Evolution in Acute Ischemic Stroke Is Determined by Vessel Status
02:00 PM - 06:30 PM Abstract 184 - Multiple Telescoping Self Expanding Stents Effectively Recanalize Acute Cervical Internal Carotid Artery Dissection
02:00 PM - 06:30 PM Abstract 185 - Microcatheter to Recanalization (Procedural Time) Predicts Outcomes in Endovascular Treatment in Acute Ischemic Stroke Patients
02:00 PM - 06:30 PM Abstract 186 - Value of Other Mechanical Thrombectomy Techniques among Patients with MERCI Device Failure during Endovascular Treatment of Acute Ischemic Stroke
02:00 PM - 06:30 PM Abstract 187 - Rates of Acute Stroke Intervention after Direct Field to Hospital Inter-County Transfer: A Study on Patients from the Florida Keys
02:00 PM - 06:30 PM Abstract 188 - Intracranial Stenosis in the Young Patients May Represent a Distinct Syndrome
02:00 PM - 06:30 PM Abstract 189 - Outcome of Brainstem Strokes in Children
02:00 PM - 06:30 PM Abstract 190 - Intracerebral Hemorrhage in the Young: Risk Factors and Locations
02:00 PM - 06:30 PM Abstract 191 - Low Risk of Recurrent Stroke in Young Adults with Cryptogenic Strokes
02:00 PM - 06:30 PM Abstract 192 - Cervical Arteries Dissections: Not Always a Benign Condition of Young Subjects
02:00 PM - 06:30 PM Abstract 193 - Interictal Platelet Activation in Episodic Migraine with Aura and Large Right-to-Left Circulatory Shunt
02:00 PM - 06:30 PM Abstract 195 - Retinocochleocerebral Vasculopathy (Susac's Syndrome)
02:00 PM - 06:30 PM Abstract 196 - Ischemic Stroke and Circulating gamma delta TCR Lymphocytes
02:00 PM - 06:30 PM Abstract 197 - Platelet Activation and Nitric Oxide Synthesis in Patients with Transient Ischemic Attack
02:00 PM - 06:30 PM Abstract 198 - Cerebrovascular Events during Pregnancy, Delivery, and Puerperium
02:00 PM - 06:30 PM Abstract 199 - Bilateral Carotid and Vertebral Artery Dissections in a 32 Year Old Post-Partum Woman
02:00 PM - 06:30 PM Abstract 200 - HIV-Associated Diffuse Intracranial Giant Fusiform Aneurysms with Intraluminal Thrombosis Causing Recurrent Ischemic Strokes
02:00 PM - 06:30 PM Abstract 201 - Acute Inflammatory Stroke Study: Initial Results from a Karolinska Stroke Cohort
02:00 PM - 06:30 PM Abstract 202 - Cocaine-Induced Stroke: Who Gets Screened and Does Treatment Change If Cocaine Is Present?
02:00 PM - 06:30 PM Abstract 203 - Borderline Lowe Platelet Counts Are Associated with Cerebral Microbleeds in Patients with Acute Lacuna Infarction
02:00 PM - 06:30 PM Abstract 204 - Matrix Metalloproteinases and Their Tissue Inhibitors Are Associated with Cerebral Vasospasm after Spontaneous Subarachnoid Hemorrhage
02:00 PM - 06:30 PM Abstract 205 - Inflammation in Human Intracerebral Hemorrhage Demonstrated In Vivo with 99mTc-HMPAO Labeled Leukocytes
02:00 PM - 06:30 PM Abstract 206 - Copeptin as Prognostic Serum Biomarker in Different Acute Stroke Treatment Settings: An Interim Analysis
02:00 PM - 06:30 PM Abstract 207 - Biomarker Levels and Functional Outcome from Ischemic Cerebral Events
02:00 PM - 06:30 PM Abstract 208 - Effect of Admission Serum C-Reactive Protein on Short-Term Outcome after Acute Ischemic Stroke
02:00 PM - 06:30 PM Abstract 209 - Clinical Significance of Serum Zinc Levels in Cerebral Ischemia
02:00 PM - 06:30 PM Abstract 210 - Does Platelet Count and Mean Platelet Volume Play a Role in the Development of Subtypes of Ischemic Stroke?
02:00 PM - 06:30 PM Abstract 211 - Comparison of Differential Gene Expression in Three Mouse Strains Resistant to Cerebral Ischemia
02:00 PM - 06:30 PM Abstract 212 - Patients with Higher 18-FDG Carotid Uptake on PET Have an Increased Risk of Vascular Events
02:00 PM - 06:30 PM Abstract 213 - Low Serum Magnesium Levels at Admission Are Associated with Acute Neurological Deterioration in Ischemic Stroke
02:00 PM - 06:30 PM Abstract 214 - Assessment of Delays in Carotid Endarterectomy in Patients Referred to Neurology with Symptomatic Carotid Artery Disease
02:00 PM - 06:30 PM Abstract 215 - Prevalence and Vascular Characteristics of Doppler Ultrasound of Carotid Artery Stenosis in African American Patients with Ischemic Stroke
02:00 PM - 06:30 PM Abstract 216 - Atorvastatin and Psychomotor Agitation after Carotid Endarterectomy
02:00 PM - 06:30 PM Abstract 217 - The Risk of Carotid Endarterectomy in Patients with More Than 120 Days Since Qualifying Cerebrovascular Event
02:00 PM - 06:30 PM Abstract 218 - Postoperative Lactate Concentrations and Adverse Outcome after Carotid Endarterectomy
02:00 PM - 06:30 PM Abstract 219 - Early Hazards from Severe Carotid Stenosis: Impaired Connectivity without Symptomatic Stroke
02:00 PM - 06:30 PM Abstract 220 - Carotid Endarterectomy in Normal and High Surgical Risk Patients: A Study of Regional Variation
02:00 PM - 06:30 PM Abstract 221 - Variations in the Use of Preoperative Medications for Carotid Endarterectomy Patients
02:00 PM - 06:30 PM Abstract 222 - Specific Neurologic Manifestations of Ischemic Stroke Occurring after Cardiovascular Surgery
02:00 PM - 06:30 PM Abstract 223 - Prevalence of Intracranial Atherosclerotic Disease Coexisting with Extracranial Atherosclerosis in the North Indian Population
02:00 PM - 06:30 PM Abstract 224 - Neurosyphilis Presenting as Limbic Encephalitis
02:00 PM - 06:30 PM Abstract 225 - Tuberculous Meningitis: A Hospital Based Retrospective Analysis of Clinical Features in China
02:00 PM - 06:30 PM Abstract 226 - Cryptococcal CNS Infections among HIV-Negative, Non-Solid Organ Transplant Patients
02:00 PM - 06:30 PM Abstract 227 - Reactivation of American Trypanosomiasis (Chaga's Disease) with Cerebral Involvement in the United States
02:00 PM - 06:30 PM Abstract 228 - First Case Report of an Antemortem, Biopsy-Proven Legionella Spinal Cord Abscess
02:00 PM - 06:30 PM Abstract 229 - Increased Early Neurological and Ocular Manifestations in Neurosyphilis
02:00 PM - 06:30 PM Abstract 230 - Diagnostic Dilemma Due to an Immunological Parody: Neuro-Sarcoidosis Due to IRIS
02:00 PM - 06:30 PM Abstract 231 - Value of Ancillary Diagnostic Tests for CNS M. tuberculosis infection
02:00 PM - 06:30 PM Abstract 232 - Complication of Meningitis in Developing Countries
02:00 PM - 06:30 PM Abstract 233 - HIV-Vector Infected Monocytes Stimulate Differential Release of Proinflammatory Cytokines in Human Microglia: Investigation of the Microglial Bystander Hypothesis in Neuro-AIDS
02:00 PM - 06:30 PM Abstract 234 - Monitoring Disease Progression of HTLV-I Infected Individuals through Longitudinal Quantification of Spinal Cord Volume from MR Images
02:00 PM - 06:30 PM Abstract 235 - Neural Bystander Damage by Infiltrating Virus-Infected T Cells and the Cytotoxic T Lymphocytes in HTLV-I-Associated Neurological Disease
02:00 PM - 06:30 PM Abstract 236 - Central Nervous System T Cell Immune Activation during Neurosyphilis Infection in an HIV-Infected Individual
02:00 PM - 06:30 PM Abstract 237 - Opiates Exacerbate Neuronal Damage in SCID Mice with HIV Encephalitis
02:00 PM - 06:30 PM Abstract 238 - Stroke and Encephalopathy Associated with Death in a High-Risk Sample of Patients with HIV/AIDS
02:00 PM - 06:30 PM Abstract 239 - SCID Mice with HIV Encephalitis Treated with B18, a Novel Interferon-alpha Blocker
02:00 PM - 06:30 PM Abstract 240 - The Obvious without the Usual: A Unique Case of HIV-Related Acute Meningo-Myelo-Polyradiculopathy (AMMPR)
02:00 PM - 06:30 PM Abstract 242 - Increased Expression of Inflammatory Markers in Brain of a Transgenic Rat Model of HIV-1 Infection
02:00 PM - 06:30 PM Abstract 243 - Clinical and Diagnostic Features of Patients with Compound Heterozygous A467T/W748S POLG1 Mutations: A Case Report and Review of Previous Cases
02:00 PM - 06:30 PM Abstract 244 - Prevalence of Vitamin B12 Deficiency in an Outpatient Neurology Clinic
02:00 PM - 06:30 PM Abstract 245 - Isolated Neurosarcoidosis. Case Series in Two Sarcoidosis Centers
02:00 PM - 06:30 PM Abstract 248 - Intravenous Steroid Use in the Treatment of Eclampsia-Related Posterior Leukoencephalopathy Syndrome
02:00 PM - 06:30 PM Abstract 249 - Late Diagnosis of DiGeorge Syndrome as a Cause of Lifelong Seizures
02:00 PM - 06:30 PM Abstract 250 - In Vivo IgG Deposition in Interneurons of Experimental Antiphospholipid Syndrome Mice Brains Correlates with Clinical Manifestations and Serological Tests
02:00 PM - 06:30 PM Abstract 251 - Chronic Insomnia: Night Timing and Comorbidity
02:00 PM - 06:30 PM Abstract 252 - Insomnia Characterization in Operation Enduring Freedom/Operation Iraqi Freedom Veterans with Traumatic Brain Injury and Post Traumatic Stress Disorder
02:00 PM - 06:30 PM Abstract 253 - Sleep Disordered Breathing and Insomnia Severity in Operation Enduring Freedom/Operation Iraqi Freedom Veterans with Chronic Daily Headaches
02:00 PM - 06:30 PM Abstract 254 - Frequency of Parsomnias in Patients with Non-Epileptic Seizures
02:00 PM - 06:30 PM Abstract 255 - Increased Frequency of REM Sleep Behavior Disorder in Parkinson's Disease but Not in RLS or Essential Tremor
02:00 PM - 06:30 PM Abstract 256 - A Novel Therapy for REM Sleep Behavior Disorder (RBD)
02:00 PM - 06:30 PM Abstract 257 - Quality of Sleep and the Related Factors in the Korean Patients with Non-Vertiginous Dizziness
02:00 PM - 06:30 PM Abstract 258 - Correlation of Sleep Assessment Tools in Multiple Sleep Disorders Including Narcolepsy, Idiopathic Hypersomnia and Restless Legs Syndrome
02:00 PM - 06:30 PM Abstract 259 - Periodic Limb Movements of Sleep May Increase Cardiovascular Disease as Reflected by the Ankle-Brachial Index
02:00 PM - 06:30 PM Abstract 260 - Chronotypes in Parkinson's Disease: What Are They? And What Can They Predict?
02:00 PM - 06:30 PM Abstract 261 - The Spectrum of Sleep Dysfunction in Postural Tachycardia Syndrome (POTS)
02:00 PM - 06:30 PM Abstract 262 - Advanced Wavelet Analysis of High Frequency Spectral Domains across Two Hour Intervals in Insomnia
02:00 PM - 06:30 PM Abstract 263 - Quantitative EEG and Clinical Outcome Measures in Treatment of Excessive Daytime Sleepiness with Sodium Oxybate
02:00 PM - 06:30 PM Abstract 264 - State Space Analysis of Sleep Stage Transitions in Narcoleptic Patients and Healthy Volunteers
02:00 PM - 06:30 PM Abstract 265 - Narcolepsy and Traumatic Brain Injury - Cause or Consequence?
02:00 PM - 06:30 PM Abstract 266 - High Intelligence Is Protective for Cognitive Dysfunctions and Depression in Narcolepsy Patients?
02:00 PM - 06:30 PM Abstract 267 - Evaluation of Sumatriptan-Naproxen in the Treatment of Acute Migraine Headache: A Placebo Controlled, Double Blind, Crossover Study Assessing Cognitive Function
02:00 PM - 06:30 PM Abstract 268 - Injecting under Pressure: Low CSF Pressure Headache Responsive to Botulinum Toxin Injections
02:00 PM - 06:30 PM Abstract 269 - Chronic Daily Headache in Adolescents: Initial Evaluation of an Interdisciplinary Pain Rehabilitation Program
02:00 PM - 06:30 PM Abstract 270 - Clinical Trial Design in Chronic Migraine: Lessons Learned from the NINDS CRC Chronic Migraine Treatment Trial (CMTT)
02:00 PM - 06:30 PM Abstract 271 - Comparison of Effect Size between Active and Placebo for Single Pulse Transcranial Magnetic Stimulation (spTMS) Versus Triptans for the Acute Treatment of Migraine
02:00 PM - 06:30 PM Abstract 272 - The Major Metabolite of Dihydroergotamine (DHE) after Oral Inhalation and IV Administration Does Not Significantly Contribute to the Pharmacologic Activity
02:00 PM - 06:30 PM Abstract 273 - Benefitial Effect of Botulinum Toxin Type A in Chronic and Episodic Cluster Headache - Results of an Open Study
02:00 PM - 06:30 PM Abstract 274 - Improvement of Headaches after Weight Loss by Bariatric Surgery: A Prospective Study
02:00 PM - 06:30 PM Abstract 275 - Improved Treatment Satisfaction and Confidence among Current Triptan Users Trying Sumavel[reg] DosePro[trade] (Needle-Free Subcutaneous Sumatriptan) for up to 4 Migraine Attacks
02:00 PM - 06:30 PM Abstract 276 - The CGRP Receptor Antagonist Telcagepant Does Not Demonstrate Potential for Recreational Abuse: Results from a Clinical Study
02:00 PM - 06:30 PM Abstract 277 - Outpatient Home-Based Continuous Intravenous Dihydroergotamine Therapy for Intractable Migraine
02:00 PM - 06:30 PM Abstract 278 - Ketamine Reduces the Severity of Prolonged Migraine Aura: Support for the Glutamate Hypothesis of Aura
02:00 PM - 06:30 PM Abstract 279 - High Dose of the CGRP Receptor Antagonist Telcagepant Has No Effect on 24-hr Ambulatory Blood Pressure or Heart Rate in Healthy Volunteers
02:00 PM - 06:30 PM Abstract 280 - OnabotulinumtoxinA for Chronic Migraine: Effect of Fixed-Site, Fixed-Dose Injection Paradigm on Health-Related Quality of Life in PREEMPT Clinical Program
02:00 PM - 06:30 PM Abstract 281 - A New Powdered Formulation of Diclofenac Potassium for Oral Solution: Effect on Migraine Severity, Recurrence, and Sustained Relief
02:00 PM - 06:30 PM Abstract 282 - Onabotulinum Toxin-A in Chronic Migraine (CM); 10 Years' Experience in 376 Patients Evaluated Prospectively
02:00 PM - 06:30 PM Abstract 283 - Multiple-Attack Efficacy and Tolerability Sumavel[reg] DosePro[trade] (Needle-Free Subcutaneous Sumatriptan) among Current Triptan Users
02:00 PM - 06:30 PM Abstract 284 - Long-Term Treatemnt of Chronic Cluster Headache with Occipital Stimulation
02:00 PM - 06:30 PM Abstract 285 - Migraine Recurrence Rates: Case for Standardization of the Definition
02:00 PM - 06:30 PM Abstract 286 - Safety of Lacosamide Monotherapy in Migraine Prophylaxis, Fibromyalgia, and Osteoarthritis: Placebo-Controlled Evaluations
05:00 PM - 06:30 PM Reception
Faculty Disclosures
J. Clay Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology (ABPN). The institution of an immediate family member of Dr. Goodman has received research support from NIH.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Bruce A. Cree, MD, PhD, MAS, FAAN The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care.
Joseph E. Safdieh, MD, FAAN Dr. Safdieh has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Safdieh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Dughi, Hewit & Domalewski, P.C.. Dr. Safdieh has received publishing royalties from a publication relating to health care.
Erika Driver-Dunckley, MD, FAAN Dr. Driver-Dunckley has nothing to disclose.
Bayard D. Miller, MD No disclosure on file
Anat Achiron, MD, PhD, FAAN Dr. Achiron has nothing to disclose.
No disclosure on file
Eva Havrdova, MD Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havrdova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Ruchira M. Jha, MD Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Lauren B. Krupp, MD, FAAN Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Manuela Vaneckova Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Manuela Vaneckova has received research support from Czech Ministry of Health project—grants NU 22-04-00193 . Manuela Vaneckova has received research support from Czech Ministry of Health project - RVO VFN 64165 . Manuela Vaneckova has received personal compensation in the range of $500-$4,999 for serving as a principal investigator with Czech Ministry of Health project—grants NU 22-04-00193 .
Jayne Ness, MD An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
Gabrielle A. DeVeber, MD Dr. DeVeber has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for GDEV consultants inc.
Emmanuelle Waubant, MD, PhD, FAAN The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Antonio Bertolotto, MD, FAAN Dr. Bertolotto has nothing to disclose.
Anne E. Tournay, MBBS No disclosure on file
John C. Morris, MD, FAAN Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.
Charles H. Adler, MD, PhD, FAAN Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Douglas M. Wallace, MD No disclosure on file
Ludwig Kappos, MD, FAAN Dr. Kappos has nothing to disclose.
Calin I. Prodan, MD The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
James A. Russell, DO, FAAN Dr. Russell has received publishing royalties from a publication relating to health care.
Alessia Di Sapio, MD No disclosure on file
A. D. Rothner, MD No disclosure on file
Kevin Tan, MD, FAAN Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Tan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck.
Ronald C. Petersen, MD, PhD, FAAN Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly and Co.. Dr. Petersen has received personal compensation in the range of $0-$499 for serving as a Consultant for Eisai, Inc.. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Petersen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has received publishing royalties from a publication relating to health care. Dr. Petersen has a non-compensated relationship as a Board of Directors with American Brain Foundation that is relevant to AAN interests or activities.
Heather J. Fullerton, MD The institution of Dr. Fullerton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Fullerton has received research support from NIH, AHA, Benioff Foundation.
Ellen M. Mowry, MD, FAAN Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Brett R. Dees, MD No disclosure on file
Ana De Vera, MD No disclosure on file
Douglas Feinstein, MD No disclosure on file
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Pradeep Bista No disclosure on file
Orna O'Toole, MB, BCh, BAO MD Dr. O'Toole has nothing to disclose.
Stanley H. Appel, MD, FAAN Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Rosa Rademakers, PhD Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Wazim Mohamed, MD Dr. Mohamed has nothing to disclose.
Andrew D. Hershey, MD, PhD, FAAN, FAHS, FAAN The institution of Dr. Hershey has received personal compensation in the range of $0-$499 for serving as a Consultant for Amgen. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. The institution of Dr. Hershey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Hershey has received research support from Amgen. The institution of Dr. Hershey has received research support from NIH, NINDS. The institution of Dr. Hershey has received research support from Bioahaven. The institution of Dr. Hershey has received research support from Upsher-Smith. Dr. Hershey has received publishing royalties from a publication relating to health care.
Amit Kansara, MD Dr. Kansara has nothing to disclose.
Jeff Kraakevik, MD, FAAN Dr. Kraakevik has stock in Multiple companies. The institution of Dr. Kraakevik has received research support from Parkinson Foundation. The institution of Dr. Kraakevik has received research support from Syngeric.
Murali Ramanathan, PhD The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Archie Ong, MD No disclosure on file
Laura B. Rosen, MD, PhD No disclosure on file
Chunfeng Liu No disclosure on file
Jacek Losy, MD No disclosure on file
James E. Siegler III, MD Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siegler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serb. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wallaby Phenox. Dr. Siegler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke: Vascular and Interventional Neurology. Dr. Siegler has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Precision Medicine, LLC. The institution of Dr. Siegler has received research support from Philips. The institution of Dr. Siegler has received research support from Medtronic.
Xuemei Cai, MD, FAAN Dr. Cai has received personal compensation for serving as an employee of Pfizer. Dr. Cai has stock in Pfizer.
Matthew J. Baker, MD No disclosure on file
Hongyan Li, MD, PhD, FAAN Dr. Li has nothing to disclose.
Mi-young Jung No disclosure on file
Mariza Daras, MD Dr. Daras has nothing to disclose.
Dalia Lorenzo, MD No disclosure on file
Liliana B. Patrucco, MD Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Frederick Holdbrook Frederick Holdbrook has received personal compensation for serving as an employee of Amicus Therapeutics, Inc. Frederick Holdbrook has stock in Amicus Therapeutics, Inc.
Daniel R. Wynn, MD Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mylan. Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wynn has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Wynn has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Wynn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Banner Life. Dr. Wynn has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Biogen. The institution of Dr. Wynn has received research support from Novartis. The institution of Dr. Wynn has received research support from Sanofi. The institution of Dr. Wynn has received research support from Adamas Pharmaceutics. The institution of Dr. Wynn has received research support from EMD Serono. The institution of Dr. Wynn has received research support from Roche. Dr. Wynn has a non-compensated relationship as a Director, Consultants in Neurology Comprehensive Care Center with National MS Society that is relevant to AAN interests or activities.
Jonathan B. Strober, MD Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Strober has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Strober has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pediatric Neurology. Dr. Strober has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Many Law Firms. The institution of Dr. Strober has received research support from Anonymous. The institution of Dr. Strober has received research support from PTC. The institution of Dr. Strober has received research support from Fibrogen. The institution of Dr. Strober has received research support from Jansen. The institution of Dr. Strober has received research support from Biohaven.
Takeshi Yamada No disclosure on file
Maria Alejandra Gonzalez Duarte, MD, FAAN Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Stephen D. Silberstein, MD, FAAN Dr. Silberstein has received publishing royalties from a publication relating to health care.
Sheena K. Aurora, MD Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Joseph H. Lee, DrPH MPH BS No disclosure on file
Steven K. Feske, MD Dr. Feske has received publishing royalties from a publication relating to health care.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Jan Krasensky, MD No disclosure on file
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Chen Lin, MD The institution of Dr. Lin has received research support from VA.
Tia Aryal, MD No disclosure on file
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Brandon R. Barton, MD, FAAN Dr. Barton has nothing to disclose.
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Olga Klepitskaya, MD, FAAN Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Klepitskaya has or had stock in Neurocrine Biosciences.
Pradeep K. Sahota, MD, FAAN The institution of Dr. Sahota has received research support from VA Merit award.
Sigal Tal, MD No disclosure on file
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
John W. Lindsey, MD Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Amit Verma, MD, MBBS, FAAN No disclosure on file
Maureen Leehey, MD, FAAN Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research and Consulting. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Leehey has received personal compensation in the range of $0-$499 for serving as a Consultant for Sphenix Global Insight. Dr. Leehey has received personal compensation in the range of $0-$499 for serving as a Consultant for Olson Research Group. The institution of Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris Medicine. The institution of Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huron Consulting Services. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zynerba. The institution of Dr. Leehey has received research support from Michael J Fox Foundation. The institution of Dr. Leehey has received research support from Colorado Dept of Public Health and Environment. The institution of Dr. Leehey has received research support from Biogen. The institution of Dr. Leehey has received research support from US World Meds. The institution of Dr. Leehey has received research support from Vtesse. The institution of Dr. Leehey has received research support from NeuroDerm. The institution of Dr. Leehey has received research support from Denali. The institution of Dr. Leehey has received research support from Neuraly. The institution of Dr. Leehey has received research support from NINDS.
Justyna Sarna, MD No disclosure on file
Joseph Hentz No disclosure on file
Van Halbach, MD No disclosure on file
Moses Rodriguez, MD, FAAN Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Nizar Souayah, MD, FAAN Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Sheryl Martin-Schild, MD, PhD, FAAN No disclosure on file
Sandipan Pati, MD Dr. Pati has nothing to disclose.
Fen Bao Fen Bao has nothing to disclose.
Noel Carlson, PhD The institution of Mr. Carlson has received research support from Biogen. Mr. Carlson has received personal compensation in the range of $100,000-$499,999 for serving as a Employee as a Researcher with Veteran Affairs.
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Silvia Rossi, MD No disclosure on file
Dietrich Haubenberger, MD, FAAN Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.
Rajiv Magge, MD An immediate family member of Dr. Magge has received personal compensation for serving as an employee of Doximity. Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG Clinical. Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ASCO. Dr. Magge has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Medplace. Dr. Magge has received personal compensation in the range of $5,000-$9,999 for serving as a Founding Medical Content Contributor with Roon.
Tony W. Ho, MD No disclosure on file
Jeremy M. Shefner, MD, PhD, FAAN Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $0-$499 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuvivo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nura BIo. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prilenia. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a grant review chair with DOD- General Dynamics.
Iordanis Evangelou No disclosure on file
Aleksandra Pikula, MD The institution of Dr. Pikula has received research support from CIHR.
Ya-Ping Yang No disclosure on file
Monica Rojas, MD No disclosure on file
Basil T. Darras, MD The institution of Dr. Darras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Darras has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. The institution of Dr. Darras has received research support from National Institutes of Health/National Institute of Neurological Disorders and Stroke,. The institution of Dr. Darras has received research support from Slaney Family Fund for SMA. The institution of Dr. Darras has received research support from Spinal Muscular Atrophy Foundation. The institution of Dr. Darras has received research support from CureSMA. The institution of Dr. Darras has received research support from Working on Walking Fund . The institution of Dr. Darras has received research support from CHERISH, CS2/CS12 . The institution of Dr. Darras has received research support from Biogen for CS11. The institution of Dr. Darras has received research support from AveXis. The institution of Dr. Darras has received research support from Sarepta Pharmaceuticals. The institution of Dr. Darras has received research support from PTC Therapeutics. The institution of Dr. Darras has received research support from Roche. The institution of Dr. Darras has received research support from Santhera. The institution of Dr. Darras has received research support from Scholar Rock. The institution of Dr. Darras has received research support from Fibrogen. The institution of Dr. Darras has received research support from Summit. Dr. Darras has received publishing royalties from a publication relating to health care. Dr. Darras has received publishing royalties from a publication relating to health care.
Jonathan L. Carter, MD Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Jo Anne Turner, APRN No disclosure on file
William J. Burke, MD, PhD, FAAN No disclosure on file
Shoji Tsuji, MD, PhD The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Wolfgang Brueck, PhD Dr. Brueck has nothing to disclose.
Fethi Idiman, MD No disclosure on file
John C. Morgan, MD, PhD Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Morgan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Morgan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various Civil Cases. Dr. Morgan has received personal compensation in the range of $5,000-$9,999 for serving as a Rater with Praxis.
Wendy G. Mitchell, MD Dr. Mitchell has nothing to disclose.
Salvador Cruz-Flores, MD, FAAN The institution of Dr. Cruz-Flores has received research support from University of Texas System.
Jerry N. Pruitt II, MD No disclosure on file
Robert Zivadinov, MD, PhD, FAAN The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
David J. Capobianco, MD, FAAN No disclosure on file
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Kenkichi Nozaki, MD No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH.
Sylvia M. Lucas, MD, PhD No disclosure on file
Ondrej Dolezal, MD No disclosure on file
Robert P. Lisak, MD, FAAN Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Barbara S. Pedley, MD, FAAN No disclosure on file
Omar Khan, MD, FAAN Dr. Khan has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Khan has received personal compensation in the range of $100,000-$499,999 for serving as a Director of Epilepsy Center with Veterans Affairs. An immediate family member of Dr. Khan has received personal compensation in the range of $100,000-$499,999 for serving as a Clinical Reviewer with FDA.
Martin McKeown, MD No disclosure on file
Deborah Hirtz, MD, FAAN No disclosure on file
Chandni P. Kalaria, MD No disclosure on file
Steven Jacobson Steven Jacobson has nothing to disclose.
Gordon S. Francis, MD, FAAN No disclosure on file
Dessa Sadovnick, PhD No disclosure on file
Bruno E. Vidal, MD No disclosure on file
Peter J. Dyck, MD, FAAN Dr. Dyck has nothing to disclose.
Laura Willis, BA No disclosure on file
Siddharth Sehgal, MD Dr. Sehgal has nothing to disclose.
Xiaojun You, PhD No disclosure on file
Christian Baumann, MD No disclosure on file
Donald W. Lewis, MD, FAAP No disclosure on file
Jill T. Jesurum, PhD No disclosure on file
Vicki A. Ramsey-Williams, MD, PhD Dr. Ramsey-Williams has nothing to disclose.
Mark Hallett, MD, FAAN Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Jackie Durfee No disclosure on file
Eric Pearlman, MD Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co.
Brendon P. Boot, MD, MBBS Dr. Boot has received personal compensation for serving as an employee of BlueRock Therapeutics. Dr. Boot has stock in Eyepoint Pharmaceuticals.
Ninan T. Mathew, MD No disclosure on file
Karen C. Albright, DO, DO, PhD, MS, MPH Dr. Albright has nothing to disclose.
Dana Horakova Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dana Horakova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Hannah Gardener, ScD Ms. Gardener has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intersocietal Accreditation Commission. Ms. Gardener has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ellipse Analytics. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Baum Hedlund. Ms. Gardener has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with A Green Slate Consulting.
Min-Suk Yoon, MD No disclosure on file
Mahmoud Rayes, MD No disclosure on file
Nathan Pankratz, PhD No disclosure on file
Natalie Aucutt-Walter, MD No disclosure on file
Carolina Valdes, MD No disclosure on file
Makoto Kawai, MD Dr. Kawai has nothing to disclose.
Mira Katan, MD No disclosure on file
Gerhard Bauer No disclosure on file
Kinshuk Sahaya, MD, FAES, FAAN Dr. Sahaya has nothing to disclose.
Anita T. Wu, MD No disclosure on file
Gyanendra Kumar, MD, FAAN Dr. Kumar has received personal compensation in the range of $500-$4,999 for serving as a Medical Consultant with Arizona Medical Board.
Andrew L. Chan, MD No disclosure on file
Jorge Oksenberg, MD No disclosure on file
Ana-Marisa Lagman-Bartolome, MD Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Searchlight. Dr. Lagman-Bartolome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Lagman-Bartolome has received research support from AMGEN. The institution of Dr. Lagman-Bartolome has received research support from Abbvie. The institution of Dr. Lagman-Bartolome has received research support from Lundbeck. Dr. Lagman-Bartolome has received publishing royalties from a publication relating to health care.
Francis J. DiMario, Jr., MD No disclosure on file
Stela Lefter, MD No disclosure on file
Kamal R. Shah, MD No disclosure on file
Seemant Chaturvedi, MD, FAHA, FAAN Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Chaturvedi has received research support from NINDS.
David W. Dodick, MD, FAAN Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical 好色先生 Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with 好色先生 that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Amy T. Towfighi, MD Dr. Towfighi has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law firms. The institution of Dr. Towfighi has received research support from NIH.
Thomas F. Scott, MD Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Elsdon Storey, FRACP, DPhil No disclosure on file
Nigel C. Tan, MBBS No disclosure on file
Deborah H. Hall, MD, PhD, FAAN Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Sean J. Pittock, MD, FAAN Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Holly A. Shill, MD, FAAN Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Marwan N. Sabbagh, MD, FAAN Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
John N. Caviness, MD, FAAN Dr. Caviness has nothing to disclose.
Valter Troni, MD No disclosure on file
Tanuja Chitnis, MD, FAAN Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Bridget T. Carey, MD No disclosure on file
Robert E. Chen, MD, MBBChir Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Chen has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International Federation of Clinical Neurophysiology. Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Chen has received research support from Canadian Institutes of Health Research. The institution of Dr. Chen has received research support from Natural Science and Engineering Research Council of Canada. Dr. Chen has received research support from Parkinson Foundation. The institution of Dr. Chen has received research support from National Organization for Rare Disease. The institution of Dr. Chen has received research support from Abbvie.
Frederick J. Derosier, DO No disclosure on file
Sherry Hsiang-Yi Chou, MD Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of NIH. An immediate family member of Dr. Hsiang-Yi Chou has received personal compensation for serving as an employee of Wells Fargo. Dr. Hsiang-Yi Chou has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Grace Therapeutics. The institution of Dr. Hsiang-Yi Chou has received research support from The Neurocritical Care Society. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Board of Director member with United Council of Neurologic Specialties that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair-elect, the Neurocritical Care Committee with American Heart Association, the Stroke Council that is relevant to AAN interests or activities. Dr. Hsiang-Yi Chou has a non-compensated relationship as a Co-chair/chair ellect, the Neurocritical Care Special Interest Group with American Neurologic Association that is relevant to AAN interests or activities.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
William J. Powers, MD, FAAN Dr. Powers has a non-compensated relationship as a Chair of the Writing Group for Acute Ischemic Stroke Guidelines with American Heart Association that is relevant to AAN interests or activities.
Cindy Fuller No disclosure on file
Heinrich P. Mattle, MD No disclosure on file
J. Theodore Phillips, MD, PhD, FAAN No disclosure on file
Ramesh Madhavan, MD, FAAN Dr. Madhavan has received stock or an ownership interest from TiaTech USA and TiaTech India. Dr. Madhavan has received intellectual property interests from a discovery or technology relating to health care.
Carlos S. Kase, MD, FAHA, FAAN Dr. Kase has nothing to disclose.
J. Douglas Miles, MD, PhD, FAAN Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
Daune L. MacGregor, MD, FAAN No disclosure on file
Mikolaj Pawlak, MD PhD Dr. Pawlak has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgalign . Dr. Pawlak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inteneural Networks Inc. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RSQ. Dr. Pawlak has received publishing royalties from a publication relating to health care.
Lucia V. Schottlaender, MD No disclosure on file
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Nancy L. Kuntz, MD, FAAN Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
John W. Rose, MD, FAAN The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Megha Shah Megha Shah has received personal compensation for serving as an employee of AbbVie. Megha Shah has stock in AbbVIe .
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Niels Bergsland Prof. Bergsland has nothing to disclose.
Andreas J. Plaitakis, MD No disclosure on file
Brian McNamara, MD Dr. McNamara has nothing to disclose.
Fernando Dangond, MD, FAAN Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Joshua P. Klein, MD, PhD, FANA, FAAN Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer Publishers. Dr. Klein has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for various law firms. Dr. Klein has received publishing royalties from a publication relating to health care.
Manal A. Badawi, MD Dr. Badawi has nothing to disclose.
Rohini Coorg, MD Dr. Coorg has nothing to disclose.
Katharina M. Busl, MD, MS, FAAN Dr. Busl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Rissman Law. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huffman Powell Baley. Dr. Busl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for University Science. Dr. Busl has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SCCM. Dr. Busl has a non-compensated relationship as a Board Member with Art in Medicine that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Associate Editor with Critical Care Explorations that is relevant to AAN interests or activities. Dr. Busl has a non-compensated relationship as a Assistant Editor with Neurocritical Care that is relevant to AAN interests or activities.
Grisel J. Lopez, MD Dr. Lopez has nothing to disclose.
Unsong Oh, MD Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
James A. Charles, MD, FAAN No disclosure on file
Paul Winner, DO, FAAN Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. The institution of Dr. Winner has received research support from Amgen. The institution of Dr. Winner has received research support from Allergan. The institution of Dr. Winner has received research support from Lundbeck . The institution of Dr. Winner has received research support from Novartis. The institution of Dr. Winner has received research support from Lilly. The institution of Dr. Winner has received research support from Teva. The institution of Dr. Winner has received research support from Supernus. The institution of Dr. Winner has received research support from Biogen. The institution of Dr. Winner has received research support from Avinar. The institution of Dr. Winner has received research support from SAMUS.
Corneliu A. Bulboaca, MD, FAAN No disclosure on file
Stu J. Glassner, DO Dr. Glassner has nothing to disclose.
David H. Margolin, MD, PhD Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Raya Massoud, MD No disclosure on file
Ania Weck No disclosure on file
Kerri Schoedel No disclosure on file
Robert D. Henderson, FRACP No disclosure on file
Jan L. Brandes, MD Dr. Brandes has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Brandes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Brandes has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Lilly. Dr. Brandes has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Amgen. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Brandes has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Brandes has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Lewis Thomason. Dr. Brandes has received research support from Amgen. Dr. Brandes has received research support from Teva. Dr. Brandes has received research support from Allergan. Dr. Brandes has received research support from Biohaven. Dr. Brandes has a non-compensated relationship as a Board Member with National Headache Foundation that is relevant to AAN interests or activities.
Swapan Dholakia, MD No disclosure on file
Bethanie N. Morgan, MD Dr. Morgan has nothing to disclose.
Tobias Kurth, MD, ScD, FAAN Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TotalEnergies. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly & Company. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. The institution of Dr. Kurth has received research support from German Joint Committee. The institution of Dr. Kurth has received research support from Ministry of Health.
Farhan Siddiq, MD Dr. Siddiq has nothing to disclose.
Ging-Yuek R. Hsiung, MD, FAAN Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Hsiung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. The institution of Dr. Hsiung has received research support from CIHR. The institution of Dr. Hsiung has received research support from NIH. The institution of Dr. Hsiung has received research support from Eli Lilly. The institution of Dr. Hsiung has received research support from Biogen.
James M. Stankiewicz, MD, FAAN Dr. Stankiewicz has received personal compensation for serving as an employee of Novartis.
Joab Chapman, MD, PhD Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Devin D. Mackay, MD, FAAN Dr. Mackay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Optum. Dr. Mackay has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for various law firms.
David R. Smith III, MD No disclosure on file
Eun-Yeon Joo, MD Dr. Joo has nothing to disclose.
Seung B. Hong, MD No disclosure on file
Rahul H. Damani, MD Dr. Damani has nothing to disclose.
Camilo Toro, MD, FAAN Dr. Toro has received personal compensation in the range of $100,000-$499,999 for serving as a TORO with NIH/IRP.
Catherine C. Turkel, Pharm No disclosure on file
Tunde Csepany, MD Dr. Csepany has nothing to disclose.
Natalia Murinova, MD, FAAN Dr. Murinova has nothing to disclose.
Ambooj Tiwari, MD Dr. Tiwari has nothing to disclose.
Scott R. Millis, PhD No disclosure on file
Suzanne Bourque, MD No disclosure on file
Jennifer L. Cox, PhD Dr. Cox has nothing to disclose.
John R. Perfect, MD No disclosure on file
Philip De Jager, MD, PhD Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Coleman Martin, MD Dr. Martin has nothing to disclose.
Christopher Grunseich, MD The institution of Dr. Grunseich has received research support from AnnJi Pharmaceuticals.
Arnaud Lacour No disclosure on file
Alison Baird, MBBS, PhD, FRACP, MPH The institution of Dr. Baird has received research support from NIH. The institution of Dr. Baird has received research support from NIH. The institution of Dr. Baird has received research support from Research Foundation of SUNY. Dr. Baird has received intellectual property interests from a discovery or technology relating to health care. Dr. Baird has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Maimonides Medical Center.
Joerg R. Kraus, MD No disclosure on file
Yuval Karmon, MD No disclosure on file
William T. Hu, MD, PhD, FAAN Dr. Hu has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fujirebio. Dr. Hu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman Coulter. Dr. Hu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apellis Pharmaceuticals. The institution of Dr. Hu has received research support from NIA. The institution of Dr. Hu has received research support from TMCity Foundation. The institution of Dr. Hu has received research support from Atlanta Family Foundation. The institution of Dr. Hu has received research support from Fujirebio Diagnostics.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Andro Zangaladze, MD, PhD, FAAN No disclosure on file
Keith R. Edwards, MD, FAAN No disclosure on file
Steve Verreault, MD The institution of Dr. Verreault has received research support from BMS. The institution of Dr. Verreault has received research support from Portola. The institution of Dr. Verreault has received research support from Daichii Sankyo.
Maria G. Marrosu No disclosure on file
Katherine A. Riester, MPH No disclosure on file
Anne H. Cross, MD, FAAN Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
David Hojnacki, MD, FAAN Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hojnacki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hojnacki has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Hiroshi Mitsumoto, MD, FAAN Dr. Mitsumoto has nothing to disclose.
Jean-Luc C. Mougeot, PhD No disclosure on file
Anmar Razak, MD Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Mounzer Kassab, MD No disclosure on file
Sreeram Ramagopalan No disclosure on file
William J. Weiner, MD No disclosure on file
Nuhad Abou Zeid, MD No disclosure on file
Imran I. Ali, MD, FAAN Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Maura Pugliatti, MD No disclosure on file
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Stig Wergeland, MD, PhD Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Wergeland has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wergeland has received research support from Biogen.
Mohamad Koubeissi, MD, FAAN Dr. Koubeissi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences.
Ashesh Mehta No disclosure on file
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Kara Luersen No disclosure on file
Anna Ticca No disclosure on file
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Ty Shang, MD No disclosure on file
Daniel Kaufer, MD, FAAN No disclosure on file
Bryan Traynor, MD The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Patrick Vermersch Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Douglas L. Arnold, MD, FAAN Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Cristina Moglia Cristina Moglia has nothing to disclose.
Maria A. Rocca Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Vera Bril, MD Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Michael K. Racke, MD Dr. Racke has received personal compensation for serving as an employee of Quest Diagnostics. Dr. Racke has or had stock in Quest Diagnostics.Dr. Racke has received intellectual property interests from a discovery or technology relating to health care.
Melissa McGowan No disclosure on file
Kenneth H. Fischbeck, MD, FAAN Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to AAN interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to AAN interests or activities.
Holly A. Hoenes, MD No disclosure on file
Mohammad S. Alhalabi, MD, FAAN No disclosure on file
Nancy Poechmann No disclosure on file
Gyula Acsadi, MD, FAAN Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Avexis. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serepta. Dr. Acsadi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Acsadi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Alaleh Raji, MD No disclosure on file
Sailaja Enduri, MD No disclosure on file
Kathleen Alwell No disclosure on file
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Agnes Jani-Acsadi, MD No disclosure on file
Jean Marie Ahorro, MD No disclosure on file
Roger L. Weir, MD, FAAN Dr. Weir has nothing to disclose.
Stephen G. Reich, MD, FAAN Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Ehud Lavi, MD No disclosure on file
Andrea Calvo, MD, PhD, FAAN Dr. Calvo has nothing to disclose.
Connie C. Marras, MD Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Nilufer Kale Icen, MD Dr. Kale has nothing to disclose.
Alberto A. Gabbai, MD No disclosure on file
Dheeraj Khurana, MD Dr. Khurana has nothing to disclose.
Walter R. Royal III, MD No disclosure on file
Richard K. Chan, MD, MBBS No disclosure on file
Richard S. Isaacson, MD, FAAN Dr. Isaacson has stock in Retain Health. The institution of Dr. Isaacson has received research support from National Institutes of Health. The institution of Dr. Isaacson has received research support from Aces for Alzheimer's. The institution of Dr. Isaacson has received research support from BrainMind. Dr. Isaacson has received publishing royalties from a publication relating to health care.
Tomotaka Yamamoto No disclosure on file
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Alcibiades Rodriguez, MD No disclosure on file
Phillip C. Mongiovi, MD Dr. Mongiovi has nothing to disclose.
Jonathan Haines, MD No disclosure on file
Benjamin R. Brooks, MD, FAAN Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with 好色先生 that is relevant to AAN interests or activities.
William R. Tyor, MD, FAAN The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH. The institution of Dr. Tyor has received research support from VHA. The institution of Dr. Tyor has received research support from NIH.
Paul S. Fishman, MD, PhD No disclosure on file
Orlando G. Barsottini, MD, PhD Dr. Barsottini has nothing to disclose.
Bharath Naravetla, MD No disclosure on file
Mateusz G. Adamski, MD, MS No disclosure on file
Kresimir Dolic, MD No disclosure on file
Ralph F. Jozefowicz, MD, FAAN Dr. Jozefowicz has nothing to disclose.
Robert A. Hauser, MD, MBA, FAAN Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Brenda L. Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Jean Baptiste Chanson No disclosure on file
Halina Offner, PhD No disclosure on file
Rachelle S. Doody, MD, PhD Dr. Doody has received personal compensation for serving as an employee of F. Hoffman-LaRoche. Dr. Doody has stock in F. Hoffman-LaRoche.
Karen Marr, BA No disclosure on file
Madhu Soni, MD, FAAN Dr. Soni has received personal compensation in the range of $500-$4,999 for serving as a Physician Lead (Honorarium) in Women Leading in Neurology Program with 好色先生.
Kimford J. Meador, MD, FAAN The institution of Dr. Meador has received research support from NIH. The institution of Dr. Meador has received research support from The Epilepsy Consortium.
William D. Arnold, MD Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Ramesh Khurana, MD, FAAN No disclosure on file
Adriano Chio, MD, FAAN Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Darin T. Okuda, MD, FAAN Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cortechs AI. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Okuda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Okuda has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Okuda has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Zenas BioPharma. The institution of Dr. Okuda has received research support from Novartis. The institution of Dr. Okuda has received research support from Alexion. Dr. Okuda has received intellectual property interests from a discovery or technology relating to health care.
Peter Wipfler Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Peter Wipfler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Anelyssa Cysne Frota D' Abreu, MD, PhD, MPH, FAAN The institution of Dr. Cysne Frota D' Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. Cysne Frota D' Abreu has received research support from Biogen. The institution of Dr. Cysne Frota D' Abreu has received research support from American College Of Radiology. The institution of Dr. Cysne Frota D' Abreu has received research support from COGNITION THERAPEUTICS, INC.. The institution of Dr. Cysne Frota D' Abreu has received research support from Eli Lilly. The institution of Dr. Cysne Frota D' Abreu has received research support from Jansen. Dr. Cysne Frota D' Abreu has received personal compensation in the range of $10,000-$49,999 for serving as a Lecturer with Pri_med.
Bernard M. Uitdehaag, MD, PhD, FAAN Dr. Uitdehaag has nothing to disclose.
Alexander U. Brandt, MD No disclosure on file
Karen Anderson No disclosure on file
Qi Rui Yang, MD, PhD No disclosure on file
Val J. Lowe, MD Dr. Lowe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AVID Radiopharmaceutical. Dr. Lowe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Inc. The institution of Dr. Lowe has received research support from AVID Radiopharmaceuticals.
Richard K. Bogan, MD Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
Shashidhar Kori, MD Dr. Kori has received personal compensation for serving as an employee of Novilla Pharma. Dr. Kori has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Satsuma Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Tonix Pharma. Dr. Kori has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Exalys Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for NewBio Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for Afsci Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trigemina Inc. Dr. Kori has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Novilla Pharma. Dr. Kori has received stock or an ownership interest from Novilla Pharma. Dr. Kori has received stock or an ownership interest from NewBio Pharma. Dr. Kori has received stock or an ownership interest from Tonix Pharma. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Reviewer of grant applications with Department of Defense.
Naim I. Kajtazi, MD No disclosure on file
Junger Tang, MD No disclosure on file
Wolfgang Grisold, MD, FAAN No disclosure on file
William T. Andrews, MD No disclosure on file
Amtul Farheen, MD, FAAN Dr. Farheen has nothing to disclose.
Lauren B. Elman, MD Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche/Genentech. Dr. Elman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Edgewise Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Elman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharamaceuticals. Dr. Elman has received publishing royalties from a publication relating to health care.
David Geldmacher, MD Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Geldmacher has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Geldmacher has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for BrownGreer. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Premier, Inc. Dr. Geldmacher has stock in Doximity. The institution of Dr. Geldmacher has received research support from Biogen. The institution of Dr. Geldmacher has received research support from Eisai. The institution of Dr. Geldmacher has received research support from Janssen. The institution of Dr. Geldmacher has received research support from National Institutes of Health. The institution of Dr. Geldmacher has received research support from Vaccinex. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a CME presenter with Medscape. Dr. Geldmacher has received personal compensation in the range of $10,000-$49,999 for serving as a CME presenter with Med Learning Group. Dr. Geldmacher has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生.
Revere P. Kinkel, MD, FAAN Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Kinkel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Kinkel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Kinkel has received research support from Department of Defense. The institution of Dr. Kinkel has received research support from PCORI. The institution of Dr. Kinkel has received research support from Sanofi.
Frederic Blanc No disclosure on file
Carlo Rinaldi, MD, PhD No disclosure on file
Leo McCluskey, MD No disclosure on file
Linda Chang, MD No disclosure on file
Robert B. Bell, MD No disclosure on file
Kamran Kabolizadeh, MD No disclosure on file
Jennifer Mandzia, MD Dr. Mandzia has nothing to disclose.
Pedro Braga-Neto, MD, PhD Dr. Braga-Neto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Braga-Neto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Arshad Majid, MD Dr. Majid has received publishing royalties from a publication relating to health care.
Amy Forst No disclosure on file
Zarife F. Sahenk, MD, PhD, FAAN Dr. Sahenk has nothing to disclose.
W. Michael Panneton, PhD No disclosure on file
Paisith Piriyawat, MD Dr. Piriyawat has nothing to disclose.
Paulo Bertolucci No disclosure on file
Kathleen U. Farmer, PsyD No disclosure on file
Jeffrey A. Loeb, MD, PhD Dr. Loeb has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Sturge Weber Foundation. Dr. Loeb has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various Law firms. The institution of Dr. Loeb has received research support from Patrick Grange Memorial Foundation. Dr. Loeb has received intellectual property interests from a discovery or technology relating to health care.
Anuradha Singh, MD, FAAN Dr. Singh has nothing to disclose.
Lisa M. Shulman, MD, FAAN The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Richard A. Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Orhun H. Kantarci, MD Dr. Kantarci has nothing to disclose.
David Gloss, MD, FAAN Dr. Gloss has received personal compensation in the range of $500-$4,999 for serving as a DUR Board Member with WV Dept of Health and Human Services.
Bruno Brochet, MD, FEAN Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for celgene. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for jansen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Prof. Brochet has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for celgene.
Robert T. Naismith, MD, FAAN Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Marc Narayansingh, MD No disclosure on file
John Q. Trojanowski, MD, PhD Dr. Trojanowski has nothing to disclose.
Iscia Lopes-Cendes, MD, PhD No disclosure on file
Gary W. Beecham, PhD The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
David Rosen, MD No disclosure on file
Kessarin Panichpisal, MD No disclosure on file
Hee Young Hwang No disclosure on file
Stephan Zuchner, MD, FAAN Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Andrew D. Goodman, MD, FAAN Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
George C. Ebers, MD No disclosure on file
Ellen Carl, MS No disclosure on file
Lori Chibnik No disclosure on file
Walter Struhal, MD No disclosure on file
Maura Brunetti No disclosure on file
Hans Luders, MD, PhD Dr. Luders has received publishing royalties from a publication relating to health care. Dr. Luders has received publishing royalties from a publication relating to health care.
Alice Chen-Plotkin, MD Dr. Chen-Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Egemen Idiman, MD No disclosure on file
Adnan Safdar, MD Dr. Safdar has nothing to disclose.
Lisa M. Bateman, MD, FRCPC The institution of Dr. Bateman has received research support from NIH/NINDS.
Douglas P. Larsen, MD Dr. Larsen has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with National Board of Medical Examiners.
Johann Sellner, MD, FAAN Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Boehringer, Celgene, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion, Biogen, Immunic, Merck, Novartis, Roche, Sanofi. Dr. Sellner has received personal compensation in the range of $0-$499 for serving as a Reviewer with Ethics Committtee.
Brian J. Murray, MD, FAAN The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Murray Grossman, MD, FAAN Dr. Grossman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Grossman has received research support from NIH.
Masud Seyal, MD, PhD, FAAN Dr. Seyal has nothing to disclose.
Thomas M. Ernst No disclosure on file
Miguel J. Lainez, MD, PhD, FAAN No disclosure on file
Yunyan Zhang, MD PhD No disclosure on file
Alberto Maud, MD Dr. Maud has nothing to disclose.
Bruce A. Perkins, MPH No disclosure on file
Sandra Magalhaes No disclosure on file
Sean Hwang, MD Dr. Hwang has nothing to disclose.
Diogo C. Haussen, MD Dr. Haussen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stryker. Dr. Haussen has received stock or an ownership interest from Viz AI.
Muhammad Farooq, MD Dr. Farooq has nothing to disclose.
James Burrell, MBBS, BA, BSc, NSW No disclosure on file
Virginia Lee, PhD Virginia Lee, PhD has nothing to disclose.
David Pitt, MD Dr. Pitt has nothing to disclose.
John F. Rothrock, MD Dr. Rothrock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Rothrock has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Dr. Rothrock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. The institution of Dr. Rothrock has received research support from AbbVie. The institution of Dr. Rothrock has received research support from Ipsen. The institution of Dr. Rothrock has received research support from Lundbeck.
Michelle Lee Jones, MD No disclosure on file
Veronica A. Bruno, MD Dr. Bruno has nothing to disclose.
Barbara Rosenthal, MD No disclosure on file
Stephen J. Farr, PhD No disclosure on file
Sudhansu Chokroverty, MD, FAAN No disclosure on file
Christiane Wegner, MD No disclosure on file
Andre C. Felicio No disclosure on file
Lien Diep, MD Dr. Diep has nothing to disclose.
Suzanne McGovern No disclosure on file
Jeffrey Waugh, MD, PhD, FAAN Dr. Waugh has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Two independent law firms. The institution of Dr. Waugh has received research support from AAN.
Carlos H. Schenck, MD Dr. Schenck has received personal compensation for serving as an employee of Physicians' 好色先生al Resource, LLC.. Dr. Schenck has received personal compensation for serving as an employee of Eisai Global Medical Affairs.
Eugene C. Lai, MD, PhD, FAAN Dr. Lai has received publishing royalties from a publication relating to health care.
Deborah A. Lee, MD, PhD No disclosure on file
Ulf Kallweit No disclosure on file
Peter A. Virsik, PhD No disclosure on file
John R. Rinker II, MD, BA Dr. Rinker has nothing to disclose.
Mohammad Uddin Kabiraj, MD No disclosure on file
Mark J. Tullman, MD Dr. Tullman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Tullman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Viela Bio.
Scott Vota, DO, FAAN No disclosure on file
Randi Hagerman Randi Hagerman has received publishing royalties from a publication relating to health care.
Lin Zhang, MD, PhD, FAAN Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for supernus. Dr. Zhang has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for supernus. The institution of Dr. Zhang has received research support from Michael J. Fox Foundation.
Andrew J. Westwood, MD, FAAN Dr. Westwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Healthcare Business Solutions UK. Dr. Westwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda.
Natalya Shneyder, MD Dr. Shneyder has nothing to disclose.
David J. Adams, MD No disclosure on file
Laura K. Desadier, DO No disclosure on file
Hiroya Naruse, MD No disclosure on file
Virgilio Gerald H. Evidente, MD, FAAN Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Evidente has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Evidente has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Evidente has received research support from CND. The institution of Dr. Evidente has received research support from Aeon. The institution of Dr. Evidente has received research support from Bukwang Pharmaceuticals. The institution of Dr. Evidente has received research support from Jazz Pharmaceuticals. The institution of Dr. Evidente has received research support from Scion Neurostim. The institution of Dr. Evidente has received research support from Theravance Biopharma. Dr. Evidente has received research support from Cerevance. Dr. Evidente has received research support from Ipsen.
Charlene Gamaldo, MD, FAAN Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Gamaldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
Mark Dolev Dolgopiat, MD No disclosure on file
Giuseppe De Michele, MD No disclosure on file
Thitiwan Simasathien, MD No disclosure on file
Hiroshi Takashima, MD, PhD Dr. Takashima has nothing to disclose.
Charles Cho No disclosure on file
David A. Roshal, DO No disclosure on file
Yu Nagashima No disclosure on file
Stephan Bickel, MD No disclosure on file
Naila Makhani, MD Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Institute for Advanced Clinical Trials for Children. The institution of Dr. Makhani has received research support from NIH/NINDS. The institution of Dr. Makhani has received research support from Charles H Hood Foundation. The institution of Dr. Makhani has received research support from National Multiple Sclerosis Society. Dr. Makhani has received personal compensation in the range of $0-$499 for serving as a contributor to online content with WebMD. Dr. Makhani has received personal compensation in the range of $500-$4,999 for serving as a contributor to a CME video podcast and newsletter with eMultiple Sclerosis Review. Dr. Makhani has received personal compensation in the range of $5,000-$9,999 for serving as a consultant with I-ACT for children.
Eliane Kobayashi, MD, PhD Dr. Kobayashi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Knight pharmaceuticals. Dr. Kobayashi has received personal compensation in the range of $0-$499 for serving as a Consultant for Creative Research Designs. Dr. Kobayashi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmacuticals. Dr. Kobayashi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Paladin Laboratories. Dr. Kobayashi has received personal compensation in the range of $0-$499 for serving as a author with Medlink .
Fernando M. Coelho, Sr., MD, PhD No disclosure on file
Patricia M. Riccio, MD No disclosure on file
Ekokobe Fonkem, DO Dr. Fonkem has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Fonkem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Fonkem has stock in Global Cancer Technology.
Anna D. Hohler, MD, FAAN Dr. Hohler has nothing to disclose.
Konstantin E. Balashov, MD, PhD, FAAN Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Sookyong Koh, MD, PhD No disclosure on file
Douglas R. Nordli, Jr., MD Dr. Nordli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ultragenyx. Dr. Nordli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate.
Steven Galetta, MD, FAAN Dr. Galetta has nothing to disclose.
Parminder Vig, PhD No disclosure on file
Yank Kwang Ik, PhD No disclosure on file
Edmund W. Cornman, MD No disclosure on file
Ramin Ansari, MD No disclosure on file
Miho Akaza, MD, PhD No disclosure on file
Sani A. Abubakar No disclosure on file
Alma R. Bicknese, MD Dr. Bicknese has nothing to disclose.
Primo M. Delgado, MD Dr. Delgado has nothing to disclose.
Sunitha Santhakumar, MD No disclosure on file
Ameer Hassan, DO Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stryker. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Penumbra. Dr. Hassan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerenovus. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Viz.ai. Dr. Hassan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Hassan has received research support from GE Healthcare.
Angela Marsili Angela Marsili has nothing to disclose.
Matthew Kozminski, DO No disclosure on file
Philippe Robert, MD No disclosure on file
Magdalena Kuzma-Kozakiewicz, MD, PhD No disclosure on file
Jun Goto, MD, PhD No disclosure on file
Richard C. Burgess, MD, PhD Dr. Burgess has nothing to disclose.
Andreas V. Alexopoulos, MD, MPH Dr. Alexopoulos has nothing to disclose.
I-Hui Lee, MD, PhD Dr. Lee has nothing to disclose.
Stephanie Khan No disclosure on file
Ernesto Cebrian No disclosure on file
Rina Aharoni, PhD No disclosure on file
Caterina Mainero, MD, PhD The institution of Dr. Mainero has received research support from Genentech.
Oivind Torkildsen No disclosure on file
Christine Cloak No disclosure on file
Haitham Hussein, MD, FAAN Dr. Hussein has nothing to disclose.
Yasushi Kisanuki, MD, FAAN Dr. Kisanuki has nothing to disclose.
Hua Yu No disclosure on file
Sujata P. Thawani, MD Dr. Thawani has nothing to disclose.
Mitchell G. Miglis, MD, FAAN Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alight Health. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint, LLC. Dr. Miglis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2nd MD. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Miglis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Van Cott and Talamante. The institution of Dr. Miglis has received research support from Dysautonomia International. The institution of Dr. Miglis has received research support from National Institute of Health. Dr. Miglis has received publishing royalties from a publication relating to health care.
Raza Khan, MD An immediate family member of Dr. Khan has received personal compensation for serving as an employee of Pfizer. Dr. Khan has received stock or an ownership interest from Amarin Corporation.
Fahmi M. Al-Senani, MBBS No disclosure on file
Adeline Vanderver, MD, FAAN An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Steven L. Lewis, MD, FAAN Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Lewis has received publishing royalties from a publication relating to health care. Dr. Lewis has a non-compensated relationship as a Secretary General with World Federation of Neurology that is relevant to AAN interests or activities.
Aki Kawasaki, MD, PhD, FAAN Dr. Kawasaki has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ophta.
Sandra Narayanan, MD, FAAN Dr. Narayanan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MicroVention.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Bradford B. Worrall, MD, MSc, FAAN The institution of Dr. Worrall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Worrall has received research support from NIH. The institution of Dr. Worrall has received research support from AHA/ASA.
Mustapha A. Danesi, MD No disclosure on file
Pasquale Montagna, MD No disclosure on file
Clarissa L. Yasuda, MD, PhD Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Julia O'Mahony Ms. O'Mahony has nothing to disclose.
Giorgia Puorro Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Elma Research. Giorgia Puorro has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Alexion.
Scott McGinnis, MD Dr. McGinnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Ana L. Delgado, MD Dr. Delgado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal.
Denis Saudeau, MD No disclosure on file
Valerio Carelli, MD, PhD Dr. Carelli has received personal compensation in the range of $0-$499 for serving as a Consultant for Chiesi Farmaceutici. Dr. Carelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi Farmaceutici.
Laura Guilhoto, MD No disclosure on file
Robert A. Taylor, MD No disclosure on file
Maria K. Houtchens, MD Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Houtchens has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Cravath. Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Beasley . Dr. Houtchens has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Biogen. The institution of Dr. Houtchens has received research support from Genzyme. The institution of Dr. Houtchens has received research support from Biogen. The institution of Dr. Houtchens has received research support from Genentech. The institution of Dr. Houtchens has received research support from Novartis.
Jessica S. Damoiseaux No disclosure on file
Immer Armendariz Betancour Immer Armendariz Betancour has nothing to disclose.
Filippo Santorelli, MD No disclosure on file
Marcy L. Tarrants, PhD, MPA No disclosure on file
Amal Kentab, MD No disclosure on file
Amaal J. Starling, MD, FAAN Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
Massimo Zeviani, MD, PhD No disclosure on file
Mark Murray, Sr., MD, PhD No disclosure on file
Caterina Tonon No disclosure on file
Njide Okubadejo, MD, FAAN The institution of Dr. Okubadejo has received research support from United Kingdom National Institute for Health and Care Research . The institution of Dr. Okubadejo has received research support from Michael J Fox Foundation for Parkinson's Research.
Imad M. Najm, MD Dr. Najm has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc. Dr. Najm has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Inc. Dr. Najm has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai Inc.
Cheryl H. Waters, MD, FAAN Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal.
Cheng Hsienlin No disclosure on file
Chun-Jen Lin No disclosure on file
Istvan Katona No disclosure on file
Gregory Norris, MD No disclosure on file
Jyh-Gong G. Hou, MD, PhD, FAAN No disclosure on file
Hubert Kwiecinski, MD, PhD No disclosure on file
Alan Pestronk, MD, FAAN The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Argenyx. The institution of Dr. Pestronk has received research support from NeuroNext.
G. David Rudd, PharmD, MS No disclosure on file
Liana Apostolova, MD, FAAN Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NIH. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Apostolova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for siemens. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Dr. Apostolova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Apostolova has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Association. The institution of Dr. Apostolova has received research support from Roche Diagnostics. The institution of Dr. Apostolova has received research support from NIA. The institution of Dr. Apostolova has received research support from Alzheimer Association. The institution of Dr. Apostolova has received research support from AVID radiopharmaceuticals. The institution of Dr. Apostolova has received research support from Life Molecular Imaging. Dr. Apostolova has a non-compensated relationship as a advisor with FDA that is relevant to AAN interests or activities.
Darren P. Wolfe, PhD No disclosure on file
Neetu Agashivala No disclosure on file
Markus Reindl, PhD The institution of Dr. Reindl has received research support from Euroimmun. The institution of Dr. Reindl has received research support from Roche.
Jacqueline Bernard, MD, FAAN Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Bernard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for 2ND MD. Dr. Bernard has received publishing royalties from a publication relating to health care.
Sumit Parikh, MD Dr. Parikh has received personal compensation in the range of $0-$499 for serving as a Consultant for Epirium. The institution of Dr. Parikh has received research support from CHAMP. The institution of Dr. Parikh has received research support from Mitochondrial Medicine Society. The institution of Dr. Parikh has received research support from Minovia. The institution of Dr. Parikh has received research support from Acadia. The institution of Dr. Parikh has received research support from Stealth. Dr. Parikh has received publishing royalties from a publication relating to health care.
Scott M. Lewis, MD, PhD No disclosure on file
Peter Lackner No disclosure on file
F. M. Cutrer, MD Dr. Cutrer has received publishing royalties from a publication relating to health care.
Gareth J. Parry, MD Dr. Parry has nothing to disclose.
Brian Wolf, MD No disclosure on file
Subramaniam Sriram, MD Dr. Sriram has nothing to disclose.
Diego Z. Carvalho, MD Dr. Carvalho has nothing to disclose.
William J. Litchy, MD, FAAN Dr. Litchy has nothing to disclose.
Richard M. Dubinsky, MD, MPH, FAAN Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to AAN interests or activities.
Stefan Schwab, MD Dr. Schwab has nothing to disclose.
Shara S. Brody, DO No disclosure on file
Michel D. Ferrari, MD, PhD Dr. Ferrari has nothing to disclose.
Archana A. Patel, MD, MPH, MSc Dr. Patel has received research support from NIH/NINDS.
James X. Tao, MD, PhD Dr. Tao has nothing to disclose.
Alexander Lossos, MD Dr. Lossos has nothing to disclose.
Agnes Supala- Berger, MD No disclosure on file
Ying Geng, MD No disclosure on file
Rachel Brookes No disclosure on file
David G. Ritacco, MD, PhD No disclosure on file
Joel Kramer, PhD The institution of Dr. Kramer has received research support from tau consortium. Dr. Kramer has received publishing royalties from a publication relating to health care.
Rocco Liguori, MD Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for HEALTHWARE GROUP s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION PHARMA ITALY s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME CORPORATION . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ECM NETWORK s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION PHARMA ITALY s.r.l.. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PTS s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ALEXION PHARMA ITALY s.r.l.. Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AIM EDUCATION s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MAYA IDEE SUD s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ISTITUTO SUPERIORE DI SANITA' . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for QbGROUP s.r.l. . Dr. Liguori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SYMPOSIUM s.r.l. . Dr. Liguori has received publishing royalties from a publication relating to health care.
Muhammad F. Suri, MD Dr. Suri has nothing to disclose.
Michael Greicius, MD Dr. Greicius has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acelot.
Hong Jiang, MD, PhD The institution of Dr. Jiang has received research support from Florida Health. The institution of Dr. Jiang has received research support from NINDS RO1.
John S. Ebersole, MD No disclosure on file
Iris O. Yung, MD No disclosure on file
Steven G. Younkin, MD, PhD No disclosure on file
Anthony Traboulsee, MD Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Dan J. Capampangan, MD, FAAN No disclosure on file
Jocelyn C. Zwicker, MD No disclosure on file
Daniel Roque, MD No disclosure on file
Jane Castelli-Haley, PhD, MBA No disclosure on file
Michael S. Vaphiades, DO No disclosure on file
Bart Demaerschalk, MD, MSc, FRCPC, FAAN Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Richard B. Lipton, MD, FAAN Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Neil C. Porter, MD No disclosure on file
Michael Schocke, MD No disclosure on file
Mark Agostini, MD Dr. Agostini has nothing to disclose.
Maria Angels Font Padros No disclosure on file
Hee Jin Kim, MD No disclosure on file
Hagen B. Huttner, MD, PhD No disclosure on file
Leon A. Weinstock, MD Dr. Weinstock has nothing to disclose.
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN Dr. Von Glehn Silva has nothing to disclose.
David C. Spencer, MD, FAAN Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuiticals. Dr. Spencer has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroPace Inc. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Various. The institution of Dr. Spencer has received research support from NIH. Dr. Spencer has received publishing royalties from a publication relating to health care. Dr. Spencer has received personal compensation in the range of $500-$4,999 for serving as a Faculty in Teaching Course supported by unrestricted educational grants with Creative 好色先生 Concepts.
Mona Sazgar, MD Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sazgar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences. The institution of Dr. Sazgar has received research support from UCB. Dr. Sazgar has received publishing royalties from a publication relating to health care.
Martin Gizzi, MD, PhD, FAAN No disclosure on file
Bettina E. Pfausler, MD No disclosure on file
Horacio Senties Madrid No disclosure on file
Alex B. Chebl, MD No disclosure on file
Apostolos P. Georgopoulos, MD No disclosure on file
Luisa Rojas, MD No disclosure on file
Erik P. Pioro, MD, DPhil, FAAN Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Rebecca Romero, MD, FAAN Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics . Dr. Romero has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Romero has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon.
Gabriel Leonard, PhD No disclosure on file
Prakash Ambady, MD No disclosure on file
Paul G. Mathew, MD, DNBPAS, FAHS, FACSM, FAAN Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Amber Salter, PhD Dr. Salter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gryphon Bio. Dr. Salter has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abata Therapeutics. Dr. Salter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sora Neuroscience. Dr. Salter has stock in Owl Therapeutics. The institution of Dr. Salter has received research support from National Multiple Sclerosis Society. The institution of Dr. Salter has received research support from Department of Defense Congressionally Directed Medical Research Program. The institution of Dr. Salter has received research support from Consortium of Multiple Sclerosis Centers.
Fernando L. Pagan, MD, FAAN Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Kinya Ishikawa, MD, PhD Dr. Ishikawa has nothing to disclose.
Elisabetta Verdun Di Cantogno, MD Dr. Verdun Di Cantogno has received personal compensation for serving as an employee of EMD Serono Research & Development Institute, Inc., Billerica, MA, USA. Dr. Verdun Di Cantogno has stock in EMD Serono Research & Development Institute, Inc., Billerica, MA, USA.
Wolfgang Nachbauer No disclosure on file
Vincent Truong, MD Dr. Truong has nothing to disclose.
Serena Spudich, MD The institution of Dr. Spudich has received research support from NIH.
Janice Y. Maldonado, MD The institution of Dr. Maldonado has received research support from Genentech.
Yasser M. Awaad, MD No disclosure on file
Joseph A. Diamond, MD Dr. Diamond has nothing to disclose.
Shazia Afridi No disclosure on file
Holger Kaube, MD No disclosure on file
Robert W. Van Boven, MD, DDS No disclosure on file
Jerzy A. Krupinski, MD, PhD No disclosure on file
Douglas S. Goodin, MD No disclosure on file
Peter Goadsby, MD, PhD, FRS Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kallyope. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seaport Therapeutics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dr Reddy's. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities.
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Paul C. Van Ness, MD, FAAN No disclosure on file
Elsa Solorzano, MD No disclosure on file
Stanley L. Cohan, MD, PhD, FAAN Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Alexandra Durr, MD The institution of Dr. Durr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Durr has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. The institution of Dr. Durr has received research support from NIH. The institution of Dr. Durr has received research support from BIOGEN. The institution of Dr. Durr has received research support from MINORYX. The institution of Dr. Durr has received research support from TRIPLETS THERAPEUTICS. The institution of Dr. Durr has received research support from Servier. The institution of Dr. Durr has received research support from ANR. The institution of Dr. Durr has received research support from PTC.
Terri J. Kiernan, NP No disclosure on file
Pratap R. Chand, MD, FRCP, FAAN Dr. Chand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. An immediate family member of Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. Chand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Neuroscience.
Choon H. Cha, MD, FAAN No disclosure on file
Samira K. Manji, MD No disclosure on file
Luanne Metz, MD The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Vijay B. Kumar No disclosure on file
Martin Rakusa, MD No disclosure on file
Allen S. Nielsen, MD No disclosure on file
Maria T. Toczek, MD No disclosure on file
Odelia Ghodsizadeh No disclosure on file
Zakiya J. Wynn, MD No disclosure on file
Sebastian F. Ameriso, MD Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Olaf Stuve, MD, PhD, FAAN Dr. Stuve has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Stuve has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Therapeutic Advances in Neurological Diseases. Dr. Stuve has received research support from US Department of Veterans Affairs. Dr. Stuve has received research support from National Multiple Sclerosis Society (US). Dr. Stuve has received research support from Merck KGaA.
Jasper R. Daube, MD, FAAN No disclosure on file
Ramon R. Diaz-Arrastia, MD, PhD, FAAN Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Elizabeth Soto Cabrera, MD No disclosure on file
Marina Mata, MD No disclosure on file
Liat Hayardeny Nisimov, PhD No disclosure on file
Seth A. Smith, PhD Dr. Smith has nothing to disclose.
Maria I. Aguilar, MD Dr. Aguilar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech.
Khurram Bashir, MD The institution of Dr. Bashir has received research support from NIH. The institution of Dr. Bashir has received research support from PICORI. The institution of Dr. Bashir has received research support from Sanofi. Dr. Bashir has received research support from GWSP. The institution of Dr. Bashir has received research support from Roche. The institution of Dr. Bashir has received research support from Novartis. The institution of Dr. Bashir has received research support from Hoffmann-La Roche.
Rebecca E. Schuele, MD No disclosure on file
Ji Y. Yun, MD Dr. Yun has nothing to disclose.
Marlene Fischer, MD No disclosure on file
Stewart J. Tepper, MD Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical 好色先生 Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' 好色先生 Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical 好色先生. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research 好色先生 Social Awareness and Training In Neurosciences.
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Alberto J. Espay, MD, FAAN Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tanabe Pharma America (formerly, Neuroderm). Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDiagnostics, Inc (SYNAPS Dx). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Intrance Medical Systems, Inc.. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis Precision Medicines. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Citrus Health. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Saeed A. Bohlega, MD No disclosure on file
Robert K. Shin, MD, FAAN Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sandoz. Dr. Shin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Shin has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Shin has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen.
Dale J. Lange, MD, FAAN No disclosure on file
Anna M. Szekely, MD No disclosure on file
Puneet K. Gupta, MD No disclosure on file
Mishkin Derakshan No disclosure on file
Timothy J. Ingall, MBBS, PhD Dr. Ingall has nothing to disclose.
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
William W. Seeley, MD Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative.
Sanjeev V. Kothare, MD, FAAN Dr. Kothare has nothing to disclose.
Eric C. Lindzen, MD, PhD No disclosure on file
William P. Cheshire, Jr., MD, FAAN Dr. Cheshire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for oxford university press. Dr. Cheshire has a non-compensated relationship as a Associate Editor with Clinical Autonomic Research that is relevant to AAN interests or activities.
Jerzy P. Szaflarski, MD, PhD, FAAN Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova Inc. Dr. Szaflarski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Gidley, Sarli & Marusak, LLP. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Szaflarski has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firm. Dr. Szaflarski has stock in AdCel Biopharma, LLC. Dr. Szaflarski has stock in iFovea.
Mark S. Forman, MD No disclosure on file
Michael J. Howell, MD, FAAN The institution of Dr. Howell has received research support from National Institutes of Health. Dr. Howell has received publishing royalties from a publication relating to health care.
Jay C. Erickson, MD No disclosure on file
Bappaditya Ray, MD Dr. Ray has nothing to disclose.
Lisa R. Rogers, DO, FAAN Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Chiara La Morgia, MD Dr. La Morgia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regulatory Pharmanet s.r.l. . Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Santhera Pharmaceuticals. Dr. La Morgia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chiesi Farmaceutici s.p.a.. The institution of Dr. La Morgia has received research support from Italian Ministry of Health.
Pei-Ning Wang, MD Dr. Wang has nothing to disclose.
Scoty Hearst No disclosure on file
Shay Menascu, MD No disclosure on file
Andrew L. Lin, MD The institution of Dr. Lin has received research support from Bristol Myers Squibb. The institution of Dr. Lin has received research support from NantOmics. The institution of Dr. Lin has received research support from Society of Memorial Sloan Kettering Cancer Center.
Perry K. Richardson, MD Dr. Richardson has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MedForce.
Daniel Martinez-Ramirez, MD Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Mexico. Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Mexico.
Isabelle Bonnaud, MD No disclosure on file
Peter Verdru, MD No disclosure on file
Sital Patel, MD No disclosure on file
Tony Daniels Tony Daniels has received personal compensation for serving as an employee of UCB. Tony Daniels has stock in UCB.
Dylan P. Blacquiere, MD Dr. Blacquiere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Blacquiere has a non-compensated relationship as a Board of Directors with Canadian Stroke Consortium that is relevant to AAN interests or activities. Dr. Blacquiere has a non-compensated relationship as a Advisory Board Member with Heart and Stroke Foundationof Canada Stroke Best Practice Recommendations that is relevant to AAN interests or activities.
Shigeo Murayama, MD, PhD No disclosure on file
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Mitsuya Morita, MD, PhD Dr. Morita has nothing to disclose.
Dileep R. Nair, MD Dr. Nair has nothing to disclose.
Bruria Ben-Zeev, MD No disclosure on file
Teepu Siddique, MD, FAAN No disclosure on file
Eduardo D. Zamora, MD No disclosure on file
Anthony Reder, MD Dr. Reder has nothing to disclose.
Beomseok Jeon, MD Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Nilufer Taner, MD, PhD, FAAN The institution of Dr. Taner has received research support from NIH.
Sridar Narayanan Sridar Narayanan has received personal compensation for serving as an employee of NeuroRx Research. Sridar Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech Inc.. The institution of Sridar Narayanan has received research support from Immunotec Inc.
Darine Kassar, MD Dr. Kassar has nothing to disclose.
Emily L. Ho, MD, PhD No disclosure on file
Gustavo J. Rodriguez, MD Dr. Rodriguez has nothing to disclose.
Richard W. Price, MD, FAAN No disclosure on file
Neill R. Graff-Radford, MD, FAAN The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Guillermo S. Garcia-Ramos, MD No disclosure on file
Cris S. Constantinescu, MD, PhD Dr. Constantinescu has received publishing royalties from a publication relating to health care.
Samip S. Patel, MD No disclosure on file
Aviva Katzav, PhD No disclosure on file
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Tricia Y. Ting, MD No disclosure on file
Jong-Min Kim, MD No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Jefferson Miley, MD No disclosure on file
Julia V. Wanschitz, MD No disclosure on file
Mohan Kottapally, MD Dr. Kottapally has nothing to disclose.
Adil Javed, MD, PhD The institution of Dr. Javed has received research support from Genentech Roche .
Sandra Rose, MD No disclosure on file
Minerva Carrasquillo The institution of Minerva Carrasquillo has received research support from NIA. The institution of Minerva Carrasquillo has received research support from Carl Angus DeSantis Foundation. The institution of Minerva Carrasquillo has received research support from Florida Department of Health. Minerva Carrasquillo has received personal compensation in the range of $500-$4,999 for serving as a Reviewer for Study Section with NIH.
Benito P. Damasceno, MD, PhD No disclosure on file
Gregor Broessner Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for TEVA. Gregor Broessner has received personal compensation in the range of $0-$499 for serving as a Consultant for Lilly. Gregor Broessner has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Gregor Broessner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly.
Christina Marra, MD, FAAN Dr. Marra has received publishing royalties from a publication relating to health care. Dr. Marra has received personal compensation in the range of $0-$499 for serving as a grant reviewer with NIH.
Siddharama Pawate, MD The institution of Dr. Pawate has received research support from Genentech. The institution of Dr. Pawate has received research support from Biogen.
Jose G. Romano, MD, FAAN Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
David J. Fink, MD, FAAN No disclosure on file
Erich Schmutzhard No disclosure on file
Magnhild Sandberg-Wollheim, MD, PhD No disclosure on file
Sydney Cash, MD Dr. Cash has received stock or an ownership interest from Beacon Biosignals.
Kerri S. Remmel, MD, PhD Dr. Remmel has nothing to disclose.
Sylvia Boesch, MD Dr. Boesch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VICO. Dr. Boesch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for REATA.
Jacek Rozniecki, MD, PhD, DSc No disclosure on file
Raimund Helbok No disclosure on file
Pamela A. McCombe, MD Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. McCombe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. The institution of Dr. McCombe has received research support from Motor Neurone Disease Resaerch Institute of Australia.
Anne S. Lindblad, PhD No disclosure on file
Asaf Achiron No disclosure on file
Tatiana Foroud, PhD The institution of Dr. Foroud has received research support from NIH. The institution of Dr. Foroud has received research support from Michael J. Fox Foundation. The institution of Dr. Foroud has received research support from Parkinson Foundation. Dr. Foroud has received personal compensation in the range of $500-$4,999 for serving as a Member of an Advisory Committee with Mayo Clinic, University of Pennsylvania, Allen Institute, Mt. Sinai, Van Andel Institute.
Jennifer W. McVige, MD, FAAN Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. McVige has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. McVige has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. The institution of Dr. McVige has received research support from Amgen. The institution of Dr. McVige has received research support from Eli Lily. The institution of Dr. McVige has received research support from Biohaven/Pfizer. The institution of Dr. McVige has received research support from Lundbeck. The institution of Dr. McVige has received research support from Dent Family Foundation. The institution of Dr. McVige has received research support from Abbvie. The institution of Dr. McVige has received research support from Teva. The institution of Dr. McVige has received research support from Theranica. Dr. McVige has a non-compensated relationship as a Neurology Board with UCNS that is relevant to AAN interests or activities. Dr. McVige has a non-compensated relationship as a Board Exam Board Member with ABPN that is relevant to AAN interests or activities.
Sandrine Aubert, MD No disclosure on file
Alicja Kalinowska-Lyszczarz, MD No disclosure on file
Shoji Matsumoto, MD No disclosure on file
Stephanie Hreha No disclosure on file
Patricio Brand, MD Dr. Brand has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Pascale Burtin, MD, PhD No disclosure on file
Travis C. Garrett, MD No disclosure on file
John A. Kamholz, MD Dr. Kamholz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. The institution of Dr. Kamholz has received research support from HDSA.
Judy Allen-Graham No disclosure on file
Hongbin Sun No disclosure on file
Michael Lee, MD No disclosure on file
Clement Pillainayagam, MD No disclosure on file
Zaira Medina, MD No disclosure on file
Nicolás Phielipp, MD, FAAN The institution of Dr. Phielipp has received research support from Asklepius Biopharmaceuticals. The institution of Dr. Phielipp has received research support from Aspen Therapeutics.
Timothy McIntire, MA No disclosure on file
Melanie Shackett No disclosure on file
Gian Marco De Marchis, MD No disclosure on file
Glenn E. Smith, MD, PhD No disclosure on file
Erin Meyer, PA No disclosure on file
Navid Seraji-Bozorgzad, MD No disclosure on file
Ericka P. Greene, MD, FAAN Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Abraham & Watkins Texas Law Firm. The institution of Dr. Greene has received research support from National Science Foundaton .
James N. Scott, MD No disclosure on file
Ming Guo, MD, PhD No disclosure on file
Brittany A. Chapman, MD No disclosure on file
Rachel P. Guimaraes, PT Ms. Guimaraes has nothing to disclose.
Sikawat Thanaviratananich, MD Dr. Thanaviratananich has nothing to disclose.
Paolo Stanzione, Prof No disclosure on file
Ravi Anand No disclosure on file
Gilles Defer, MD Dr. Defer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Defer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Eugen Trinka Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Eugen Trinka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Eugen Trinka has received research support from European Union. Eugen Trinka has received publishing royalties from a publication relating to health care.
Pamela Rist, PhD The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital. The institution of Dr. Rist has received research support from American Heart Association. The institution of Dr. Rist has received research support from Mars Edge.
Christopher F. Dowd, MD No disclosure on file
Laura Airas, MD, PhD Dr. Airas has nothing to disclose.
Valentina De Chiara, PhD No disclosure on file
Michael Rippee, MD No disclosure on file
Fusun Baumann, MD, PhD No disclosure on file
Alexandros C. Tselis, MD, PhD No disclosure on file
Richard P. Mayeux, MD, MSc, FAAN Dr. Mayeux has nothing to disclose.
Nitin Agarwal, MBBS Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai Inc.
Ammar Ahmed, MBBS, PhD, FRCP, Lond No disclosure on file
Khan Farid No disclosure on file
David Y. Huang, MD, PhD, FAAN Dr. Huang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReNeuron. Dr. Huang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for KMPHC.
Gillian L. Gordon-Perue, MD, FAAN The institution of Dr. Gordon-Perue has received research support from CDC Paul Coverdell Grant. The institution of Dr. Gordon-Perue has received research support from Florida Department of Health. Dr. Gordon-Perue has received personal compensation in the range of $500-$4,999 for serving as a Moderator with PRIME ECHO Stroke 好色先生al Webinar.
Helena W. Lau No disclosure on file
Afraa M. Musa No disclosure on file
Zaganas Ioannis, DO No disclosure on file
Caterina Motta Caterina Motta has nothing to disclose.
Jodie Burton, MD, FAAN Dr. Burton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Burton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Burton has received personal compensation in the range of $0-$499 for serving as a Consultant for Horizon. The institution of Dr. Burton has received research support from Roy and Joan Allen Professorship for Sight. Dr. Burton has a non-compensated relationship as a Advisor with CADTH that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Alexion that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a Advisor with Horizon that is relevant to AAN interests or activities. Dr. Burton has a non-compensated relationship as a 好色先生al Chair with EMD Serono that is relevant to AAN interests or activities.
Marie Y. Davis, MD, PhD Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation.
Richard F. Macko, MD No disclosure on file
Catherine Hosley, MD No disclosure on file
Adam Naj, PhD No disclosure on file
Jonathan Miller No disclosure on file
Mana Higashihara, MD No disclosure on file
Myriam Petrin, MD No disclosure on file
Dean Sherzai, MD, PhD, MAS No disclosure on file
Aaron Hoo No disclosure on file
Anna Shor, MD No disclosure on file
Ariel Stock No disclosure on file
Bradley J. Robottom, MD No disclosure on file
Li Zhang, MD No disclosure on file
Martin A. Kohli No disclosure on file
Michael Phipps, MD, MHS, FAAN Dr. Phipps has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMJ.
Christopher D. Anderson, MD, PhD, FAAN The institution of Dr. Anderson has received research support from Bayer AG. The institution of Dr. Anderson has received research support from American Heart Association. The institution of Dr. Anderson has received research support from National Institutes of Health. An immediate family member of Dr. Anderson has received publishing royalties from a publication relating to health care.
Elizabeth A. Freeman No disclosure on file
Emily C. De Los Reyes, MD Dr. De Los Reyes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biomarin .
Marco A. Rizzo, MD, PhD No disclosure on file
Rand Askalan, MD, PhD No disclosure on file
Mimi Sohn, MD No disclosure on file
Anita L. Belman, MD, FAAN No disclosure on file
Mary Payne, MD, FAAN Dr. Payne has nothing to disclose.
Jean-Louis Gastaut No disclosure on file
Rosalia C. Silvestri-Hobson, MD No disclosure on file
Gretchen E. Tietjen, MD An immediate family member of Dr. Tietjen has stock in Johnson & Johnson.
Usha T. Aryal, MD No disclosure on file
Adriana Bulboaca, MD No disclosure on file
Simon Faissner Simon Faissner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Simon Faissner has received research support from DMSG. The institution of Simon Faissner has received research support from Novartis. The institution of Simon Faissner has received research support from Lead Discovery.
Andrew Ji No disclosure on file
Robert H. Scannevin, PhD No disclosure on file
Nada El Husseini, MD, FAAN Dr. El Husseini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. El Husseini has received research support from the DISCOVERY trial funded by the National Institute of Neurological Disorders and Stroke (NINDS)and the National Institute on Aging (NIA) (U19NS115388).- subcontract from MGH. The institution of Dr. El Husseini has received research support from American Heart Association. The institution of Dr. El Husseini has received research support from PCORI.
Breen Power, MBA No disclosure on file
Maria Del Mar Saniger-Alba, MD No disclosure on file
Alessandra Musella No disclosure on file
Meeryo Choe, MD, FAAN Dr. Choe has received personal compensation for serving as an employee of Harvard-Westlake School. Dr. Choe has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Cases. The institution of Dr. Choe has received research support from NIH. Dr. Choe has a non-compensated relationship as a Board of Directors with NABIS that is relevant to AAN interests or activities. Dr. Choe has a non-compensated relationship as a Consultant with USA Swimming Concussion Task Force that is relevant to AAN interests or activities.
Nathanael Lee, MD No disclosure on file
Victoria S. Wong, MD, FAAN No disclosure on file
Matthew C. Kiernan, MBBS, PhD, FRACP The institution of Prof. Kiernan has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for British Medical Journal Publishers (UK).
Haiyan Peng No disclosure on file
Rupam Borgohain, MD No disclosure on file
Masahiro Sonoo No disclosure on file
Chandrashekhar M. Meshram, MD No disclosure on file
Mary M. Machulda, PhD The institution of Dr. Machulda has received research support from NIH.
Michael Zell No disclosure on file
John Sorkin No disclosure on file
David P. Harris, MD Dr. Harris has nothing to disclose.
Patrice Whitehead No disclosure on file
Jose Gutierrez, MD Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cardiovascular Research Foundation. Dr. Gutierrez has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for White and Rusell. Dr. Gutierrez has received research support from NIH. Dr. Gutierrez has received publishing royalties from a publication relating to health care. Dr. Gutierrez has received publishing royalties from a publication relating to health care.
Kapil D. Sethi, MD, FRCP (UK), FAAN Dr. Sethi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine.
William M. Coplin, MD, FCCM No disclosure on file
Pratik D. Bhattacharya, MD, MPH Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
John J. Millichap, MD, FAAN Dr. Millichap has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Millichap has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Millichap has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Millichap has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Praxis. Dr. Millichap has received publishing royalties from a publication relating to health care.
Sandra R. Richman, MD No disclosure on file
Jin J. Luo, MD, PhD, FAAN Dr. Luo has nothing to disclose.
Salah A. Almubarak, MD, BSc, FRCPC, CSCN, ABCN No disclosure on file
Jorg Dietrich, MD, PhD, FAAN Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Mukul Sharma, MD No disclosure on file
Ariel Majjhoo, MD No disclosure on file
Amy K. Guzik, MD, FAAN Dr. Guzik has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Local law firms, available by request.
Tammy Donnel No disclosure on file
Jeffrey Gamez No disclosure on file
Supurna Ghosh, PhD Dr. Ghosh has received personal compensation for serving as an employee of Revalesio Corporation.
Ivan Sanchez Fernandez, MD No disclosure on file
Melih Tutuncu, MD No disclosure on file
Tania B. Beltran Papsdorf, MD No disclosure on file
Sharyl R. Martini, MD, PhD Dr. Martini has nothing to disclose.
Franchette Pascual, MD No disclosure on file
Tadashi Kanouchi, MD, PhD No disclosure on file
Neha Kumar No disclosure on file
IlKyo Seo, MD No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Jamie Pak, BA No disclosure on file
Alessandro Filla, MD, FAAN No disclosure on file
Andrew Xavier, MD No disclosure on file
Sarah Z. Lu, MD, PhD No disclosure on file
Jurriaan Peters, MD Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Peters has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for CRICO. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UCB.
Juan Zhou, PhD No disclosure on file
Jessica Passanese, DO No disclosure on file
Richard Watson, MD No disclosure on file
Satoshi Kuwabara Satoshi Kuwabara has nothing to disclose.
Felix Schneider, MD No disclosure on file
Madaline B. Harrison, MD Dr. Harrison has nothing to disclose.
Camila G. Lopes, MD No disclosure on file
Lukas L. Imbach, MD No disclosure on file
Emmanuel Mulin No disclosure on file
Istvan Pirko, MD, FAAN No disclosure on file
Mustafa A. Salih, MD, FAAN No disclosure on file
Kumar Rajamani, MD, FAAN Dr. Rajamani has nothing to disclose.
Tobias Loddenkemper, MD, FAAN No disclosure on file
Max Hirshkowitz, PhD No disclosure on file
Bertrand De Toffol, MD No disclosure on file
Angus Wilfong, MD No disclosure on file
Aaron J. Johnson No disclosure on file
Nikolaos Kostulas, MD, PhD No disclosure on file
Vicki L. Wheelock, MD Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME Continuing Medical 好色先生.
Daniel Curry, MD The institution of Dr. Curry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearpoint Neuro. The institution of Dr. Curry has received research support from PTC Therapeutics. The institution of Dr. Curry has received research support from Neurogene. The institution of Dr. Curry has received research support from Grace Scientific.
Eiji Matsuura, MD Dr. Matsuura has nothing to disclose.
Sonoko Misawa, MD No disclosure on file
Chiara Pane, MD Dr. Pane has nothing to disclose.
Ezequiel A. Piccione, MD, FAAN Dr. Piccione has nothing to disclose.
Richard D. Brower, MD, FAAN No disclosure on file
Ramon L. Rodriguez Cruz, MD, FAAN The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez Cruz has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Rodriguez Cruz has received research support from Cerevance. The institution of Dr. Rodriguez Cruz has received research support from Neuraly. The institution of Dr. Rodriguez Cruz has received research support from Amneal. The institution of Dr. Rodriguez Cruz has received research support from Teva. The institution of Dr. Rodriguez Cruz has received research support from Neurocrine. Dr. Rodriguez Cruz has received publishing royalties from a publication relating to health care.
Michael Chez, MD, FAAN Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelsi. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
John M. Olichney, MD No disclosure on file
Jay Shah, MD Dr. Shah has nothing to disclose.
Ted L. Rothstein, MD No disclosure on file
Aliya Sarwar, MD Dr. Sarwar has received personal compensation in the range of $500-$4,999 for serving as a Amneal Fellowship Director Advisory Board Member with Amneal -Rytary.
Andrew Solomon, MD, FAAN Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Julien Biberon No disclosure on file
Renaud David No disclosure on file
Adam Foote No disclosure on file
Renee Low, PhD No disclosure on file
Susanta Mondal, PhD No disclosure on file
Yukari Sekiguchi No disclosure on file
Marc Raphaelson, MD, FAAN Dr. Raphaelson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharma. Dr. Raphaelson has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Patrick Dwyer, Esq.
Richard M. Trosch, MD, FAAN Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal . Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine . Dr. Trosch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
James Potts No disclosure on file
Juan G. Quispe-Cabanillas, MD No disclosure on file
Woong-Woo Lee, MD No disclosure on file
Beatriz Romo-Pardo, MD No disclosure on file
Jorge G. Burneo, MD, MSPH, FAAN Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Nigel Isaacs, PharmD, JD No disclosure on file
Adrienne N. Dula, PhD No disclosure on file
Jun Mu, MD, PhD No disclosure on file
Jonathan H. Smith, MD Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie.
Thomas A. Berger, MD Prof. Berger has received personal compensation in the range of $10,000-$49,999 for serving as a speaker at scientific meetings and participant of local and international advisory boards with various companies producing and markerting treatments for multiple sclerosis (Almirall, Biogen, Biologix, Bionorica, Celgene-BMS, Merck, Novartis, Roche, Sanofi-Genzyme, TG Therapeutics, UCB).
Jayoung Choi, MD No disclosure on file
Jungbin Shin, MD No disclosure on file
Arthur L. Hewitt No disclosure on file
Adam Carpenter, MD An immediate family member of Dr. Carpenter has received personal compensation for serving as an employee of MarPam Pharma. The institution of Dr. Carpenter has received research support from Roche. The institution of Dr. Carpenter has received research support from Immune Tolerance Network. The institution of an immediate family member of Dr. Carpenter has received research support from NIH.
Niranjan N. Singh, MD, FAAN Dr. Singh has nothing to disclose.
Mark F. Lew, MD, FAAN Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for kyowa. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Lew has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Lew has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa. Dr. Lew has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for acorda. The institution of Dr. Lew has received research support from MJFF. Dr. Lew has received research support from NIH.
Ian R.A. Mackenzie, MD, FRCP No disclosure on file
Jonathan Moses, MD No disclosure on file
Norbert Roosen, MD No disclosure on file
Mona Shahbazi No disclosure on file
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Vishal Jani, MD Dr. Jani has nothing to disclose.
Rahul Remanan, MBBS No disclosure on file
Nirav C. Shah, MBBS No disclosure on file
John R. Lynch, MD No disclosure on file
David Wustrow, PhD No disclosure on file
Steven J. Kittner, MD, MPH The institution of Dr. Kittner has received research support from NINDS.
Michael B. Cossoy, MD No disclosure on file
Christoph Kleinschnitz, MD Dr. Kleinschnitz has nothing to disclose.
Bruce S. Rubin, MD, FAAN No disclosure on file
Ziad Nasreddine, MD No disclosure on file
W D. Shields, MD No disclosure on file
Kamal Ahmad No disclosure on file
Leah Shabo No disclosure on file
Diethilde Theil, DVM No disclosure on file
Deren Huang, MD Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Huang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Macaulay Okwuokenye No disclosure on file
Rachel Omasta No disclosure on file
Welton O'Neal, Jr., PharmD No disclosure on file
Christopher Severson, MD Dr. Severson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Severson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Jonathan Tran No disclosure on file
Filippo Martinelli Boneschi No disclosure on file
Christopher Fanale, MD No disclosure on file
Russell L. Chin, MD No disclosure on file
Tatiana Plavina, PhD No disclosure on file
Paul Smith No disclosure on file
Fulton Velez No disclosure on file
Joel Salinas, MD, MBA, MSc, FAAN Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai, Inc. Dr. Salinas has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly, Inc. Dr. Salinas has stock in Isaac Health.
Temitayo Oyegbile-Chidi, MD, PhD, FAAN Dr. Oyegbile-Chidi has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Spectrum/The Transmitter. The institution of Dr. Oyegbile-Chidi has received research support from NIH.
Carmen Castrillo-Viguera Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Jeffrey Hartung, PhD No disclosure on file
Ali Hassan, MD No disclosure on file
Dana C. Hilt, MD Dr. Hilt has received personal compensation for serving as an employee of Actinogen Medical. Dr. Hilt has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brenig Therapeutics.
Emily R. Engel, MD, FAAN Dr. Engel has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Engel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Claire Tsao No disclosure on file
Mark E. Landau, MD, FAAN No disclosure on file
Ziad Hussein No disclosure on file
Lakshmi S. Amaravadi, PhD No disclosure on file
Chantale O. Branson, MD, MSCR, FAAN Dr. Branson has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Branson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.
Francisco Rocha Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Eric Klawiter, MD, FAAN Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Bella Ertik, MD No disclosure on file
Adrian Holden, MD No disclosure on file
Matthew J. Davis, MD No disclosure on file
Vivay Peter Misra, MD No disclosure on file
Nicola De Rossi Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis. Nicola De Rossi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
Elisabeth B. Lucassen, MD Dr. Lucassen has received personal compensation for serving as an employee of Novartis .
Maria Malmenäs, MSc No disclosure on file
Michel G. Clanet, Prof No disclosure on file
Andres Gonzalez, MD, FAAN Dr. Gonzalez has nothing to disclose.
Harold H. Morris III, MD, FAAN No disclosure on file
Jagkirat Singh, MBBS Dr. Singh has nothing to disclose.
Hura Behforuzi, MD No disclosure on file
Alexandre Y. Poppe, MD The institution of Dr. Poppe has received research support from Stryker. The institution of Dr. Poppe has received research support from Servier.
Harold Koendgen, MD Dr. Koendgen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Koendgen has received stock or an ownership interest from F. Hoffmann-La Roche Ltd .
Naomi Lubarr, MD Dr. Lubarr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for applied therapeutics.
Paul Matthews, MD No disclosure on file
Andreas Straube Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Andreas Straube has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis.
Robert Lenz, MD No disclosure on file
Simy K. Parikh, MD Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Parikh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Author with Medlink. Dr. Parikh has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Touch Independent Medical 好色先生 (touchIME) . Dr. Parikh has a non-compensated relationship as a Medical Advisory Board Member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
Lionel Carmant, MD No disclosure on file
Jeremy N. Rich, MD No disclosure on file
Georgios Tsivgoulis, MD, FAAN Dr. Tsivgoulis has nothing to disclose.
Christopher C. Spears, MD Dr. Spears has nothing to disclose.
Alexandra O. Duffy, MD, FAAN Dr. Duffy has nothing to disclose.
Madhureeta Achari, MD, FAAN Dr. Achari has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKinney-Taylor.
Sachin Agarwal, MD, MPH Dr. Agarwal has nothing to disclose.
Amelia K. Boehme, PhD Dr. Boehme has nothing to disclose.
Jesper Hagemeier No disclosure on file
Florencia Aguirre No disclosure on file
Alejandro Vargas, MD, MS, FAAN Dr. Vargas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer U.S. LLC Pharmaceuticals.
Erum M. Shariff, MBBS, FCPS Dr. Shariff has nothing to disclose.
Stefan Braune Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
Carolina B. Maciel, MD, MSCR, FAAN Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health.
Savary Om No disclosure on file
Philippe Major, MD Dr. Major has nothing to disclose.
Elizabeth Crabtree-Hartman, MD Dr. Crabtree-Hartman has nothing to disclose.
Abhay Kumar, MD Dr. Kumar has nothing to disclose.
Rebecca O'Dwyer, MD Dr. O'Dwyer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. O'Dwyer has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life Sciences.
Leslie E. Perry Grayson, MD Dr. Perry Grayson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals . The institution of Dr. Perry Grayson has received research support from Department of Defense .
Alok Sachdeva, MD No disclosure on file
Lidia Maria V. Moura, MD, PhD, MPH, FAAN Dr. Moura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Moura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Moura has received research support from Centers for Diseases Control and Prevention (CDC SIP20-007) . The institution of Dr. Moura has received research support from Epilepsy Foundation of America . The institution of Dr. Moura has received research support from NIH - NIA and NINDS. Dr. Moura has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Advisor with Epilepsy Foundation .
Juliana J. Coleman, MD No disclosure on file
Rahul Shah, MBBS Dr. Shah has nothing to disclose.
Eli Schwamm No disclosure on file
Janet K. Pitner, PharmD, MBA No disclosure on file
Christian Stapf, MD No disclosure on file
Bruno Maton, MD No disclosure on file
Karen Barlow, MD The institution of Dr. Barlow has received research support from Children's Hospital foundation. The institution of Dr. Barlow has received research support from Motor Accident Insurance Commission. The institution of Dr. Barlow has received research support from University of Queensland.
Claire Flaherty, PhD No disclosure on file
Brad K. Kamitaki, MD Dr. Kamitaki has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brown and Brown Absence Services Group. The institution of Dr. Kamitaki has received research support from New Jersey Health Foundation. The institution of Dr. Kamitaki has received research support from National Institute on Aging.
Deborah Raymond The institution of Ms. Raymond has received research support from NIH.
Hyunmi Choi, MD Dr. Choi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research by Elsevier. The institution of Dr. Choi has received research support from National Institute of Aging.
Jacqueline B. Stone, MD, FAAN Dr. Stone has nothing to disclose.
Ayaz M. Khawaja, MD Dr. Khawaja has nothing to disclose.
Christopher J. Deline, MD No disclosure on file
Roopali Ghandi No disclosure on file
Pitcha Chompoopong, MD Dr. Chompoopong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrazeneca. Dr. Chompoopong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam.
Christopher Wallick, PharmD Dr. Wallick has received personal compensation for serving as an employee of Genentech. Dr. Wallick has stock in Genentech.
Luis Guada-Delgado, MD Dr. Guada-Delgado has nothing to disclose.
Abdulrahman Alwaki, MD Dr. Alwaki has nothing to disclose.
Janet Benesh, BSMT No disclosure on file
Nicholas Sterling No disclosure on file
Abeer A. Khoja, MD No disclosure on file
Brandon Lucke-Wold Mr. Lucke-Wold has nothing to disclose.
Jill M. Kaspar, MD No disclosure on file
Melissa S. DiFabio No disclosure on file
Praveen Vemuri, MBBS No disclosure on file
Alex J. Linn, MD No disclosure on file
Rafael Rodriguez, MD No disclosure on file
Dareen AlShaer, MD No disclosure on file
Xian Ren No disclosure on file
Bushra Javed, MD Dr. Javed has nothing to disclose.
Yahaya O. Obiabo No disclosure on file
Hirsh Kaveeshvar, MD No disclosure on file
Syed A. Shah, MD Dr. Shah has nothing to disclose.
Jessica Magid-Bernstein, MD, PhD Dr. Magid-Bernstein has nothing to disclose.
Cecilia Vidal, MD No disclosure on file
Ashhar Ali, DO, FAAN Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Ali has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebsco.
Andrea Boan, PhD, MSCR No disclosure on file
Edouard Kamel, MD Dr. Kamel has nothing to disclose.
David Miller No disclosure on file
Richard D. Dortch, PhD Dr. Dortch has nothing to disclose.
Robert L. Carruthers, MD Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Kristen Berube No disclosure on file
Varun B. Shah, MD Dr. Shah has nothing to disclose.
Patrick J. Bergquist, MD Dr. Bergquist has nothing to disclose.
Rebecca Michael, MD No disclosure on file
Waqar Hafeez, MD No disclosure on file
Sonam C. Bhalla, MD Dr. Bhalla has nothing to disclose.
Omar A. Danoun, MD Dr. Danoun has nothing to disclose.
Muhammad Ubaid Hafeez, MD Dr. Hafeez has nothing to disclose.
Pirouz Piran, MD No disclosure on file
Carolyn Cronin, MD, PhD, FAAN Dr. Cronin has nothing to disclose.
Karen Schreiber No disclosure on file
Matthew Schrag, MD No disclosure on file
Thomas A. Buckley, PhD The institution of Dr. Buckley has received research support from Highmark Bluecross Blue Prints. The institution of Dr. Buckley has received research support from NIH/NINDS. The institution of Dr. Buckley has received research support from StateSpace, Inc.
Ihtesham Qureshi, MD No disclosure on file
Daniel Golan, MD No disclosure on file
Francisco Eduardo Ramirez, MD Dr. Ramirez has nothing to disclose.
Prateek Thatikunta, MD No disclosure on file
Sushma Chennubhotla, MD No disclosure on file
Esther Shamir No disclosure on file
Tapan Abrol, MD No disclosure on file
Michael Johnson, PhD No disclosure on file
Christoph Mayer No disclosure on file
Joana C. Dias, MD No disclosure on file
Tharick A. Pascoal, Sr., MD, PhD Dr. Pascoal has nothing to disclose.